The QualityStocks Daily Tuesday, July 2nd, 2019

Today's Top 3 Investment Newsletters

StockMarketWatch (AMRWW) +102.38%

QualityStocks (WSCRF) +50.00%

NetworkNewsWire (RNWR) +50.00%

The QualityStocks Daily Stock List

SilverSun Technologies, Inc. (SSNT)

NetworkNewsWire, Market Chameleon, Stocktwits, Marketwired, Proactive Investors, Zacks, Tip Ranks, Marketbeat, 4-Traders, The Street, Street Insider, InvestingNote, Business Insider, OTC Markets, Simply Wall St, InvestorsHub, and MarketWatch reported earlier on SilverSun Technologies, Inc. (SSNT), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

SilverSun Technologies, Inc. is a business application, technology and consulting company. It provides strategies and solutions to meet its clients' information, technology, business management, and network and cybersecurity requirements. The Company’s main operating subsidiary is SWK Technologies. SilverSun offers solutions for accounting and business management, financial reporting, Enterprise Resource Planning (ERP), Warehouse Management Systems, Customer Relationship Management (CRM), and Business Intelligence. The Company is headquartered in East Hanover, New Jersey.

In 2018, SilverSun Technologies’ wholly-owned subsidiary, SWK Technologies, acquired Info Sys Management, Inc. (ISM). ISM is a leading Portland, Oregon-based reseller of Sage Software and Acumatica solutions. In addition, ISM provides hosting services for business applications to customers across the United States.

SilverSun Technologies engages in the acquisition and build-out of technology and software companies involved in providing transformative business management solutions and professional consulting services to small- and medium-sized businesses in the manufacturing, distribution and service industries. SilverSun also has its own development staff building software solutions for Electronic Data Interchange, time and billing and an array of ERP enhancements.

The Company’s services and technologies deliver context-relevant insight and perspective into critical business operations. This enables SilverSun’s clients to manage, protect and monetize their enterprise assets - on premise or in the cloud. The Company’s proprietary, feature-rich and user-friendly EDI software is MAPADOC™. This software enables businesses to considerably cut data entry time through eliminating duplicate entries. The software also enables businesses to reduce costly errors with trading partners and to lessen mapping time by more than 75 percent.

Recently, SilverSun Technologies announced that subsidiary, SWK Technologies, acquired Partners in Technology, Inc. (PIT). PIT is a foremost reseller of Sage Software solutions, servicing more than 160 customers in the Chicago area.

SilverSun Technologies also recently provided an update on its Cybersecurity-as-a-Service business launched in July of last year. The service is provided by its wholly-owned subsidiary, Critical Cyber Defense Corporation (CCDC), in partnership with CyberHat, a top Israeli Security Operations Center (SOC). The new cybersecurity service offering enables partners and customers to leverage SilverSun’s leading security operations teams to meet their cybersecurity needs.

Moreover, SWK Technologies has announced that it now offers comprehensive application hosting services. BACH (Business Application Cloud Hosting) is an all-inclusive hosting service for ERP, CRM, network monitoring software, and other business management applications. It leverages secure cloud connections to maintain client systems through off-site servers. The service was added to SWK via the acquisition of Information Systems Management, Inc. (ISM) in 2018, and is now fully available to the SWK's customers.

SilverSun Technologies, Inc. (SSNT), closed Tuesday's trading session at $2.79, off by 7.6159%, on 4,118 volume with 27 trades. The average volume for the last 3 months is 14,601 and the stock's 52-week low/high is $2.00/$4.55999994.

chart

FISION Corp. (FSSN)

NetworkNewsWire, Penny Stock Tweets, Stockhouse, InvestorsHub, InvestorPoint, The Street, Wallet Investor, Market Screener, OTC Markets, Stockwatch, Dividend Investor, Investing, YCharts, Barchart, TradingView, MarketWatch, Business Wire, GuruFocus, and Capital Market Access reported earlier on FISION Corp. (FSSN), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

FISION Corp. is a cloud-based digital asset management and marketing automation company. It serves  enterprise clients in the healthcare, hospitality, financial/insurance, software, and technology industries. The Company is an effective sales enablement and marketing asset management tool. Established in 2011 and OTCQB-listed, FISION is based in Minneapolis, Minnesota.

FISION maximizes the brand potential of every sales interaction. The Company’s advanced, proprietary technology specializes in managing customers’ brand and marketing content. This enables marketing and sales people to quickly and easily create compelling, personalized, on-brand communications that increase revenue and profits. 

FISION equips marketing and sales teams with a wide-ranging  set of enablement capabilities built to solve distributed marketing challenges. FISION’s solutions include simplified brand distribution, sales enablement, distributed & localized marketing, digital asset management, channel support, and measurement & analytics. FISION’s centralized, cloud-based library supports manifold different file types. It gives a client complete control over how company assets are stored, retrieved, and used.

FISION completed the acquisition of Volerro Corporation (Minneapolis, Minnesota-based) following the announcement of a definitive purchase agreement on April 25, 2017. Volerro is a leader in cloud-based content collaboration and agile marketing technology. Volerro enhances the FISION platform with complementary cloud-based collaboration, agile marketing, and sales enablement software.  Volerro’s ReVu.Me cloud app allows team members to work on the same document in real-time with integrated chat and voice conferencing.

In August 2018, FISION announced a merger agreement with Continuity Logic LLC. FISION's "front of the house" sales and marketing solution is complemented by Continuity Logic's "back of the house" enterprise integration & user-friendly application interface. This agreement in 2018 allowed both companies to immediately take advantage of each others customer base and sales pipeline, with no current overlapping of clients.

In October 2018, FISION announced it was named the #1 software company in Minnesota by Twin Cities Business (TBC) magazine. FISION is the category winner in the publication’s 2018 Best of Business Reader’s Choice Awards. FISION currently has greater than 65,000 users across 21 countries.

FISION Corp. (FSSN), closed Tuesday's trading session at $0.043, up 20.9564%, on 60,080 volume with 7 trades. The average volume for the last 3 months is 110,638 and the stock's 52-week low/high is $0.023/$0.229900002.

chart

Hummingbird Resources PLC (HUMRF)

MarketWatch, Wallstreet Online, Stockhouse, Mining Stock Valuator, 4-Traders, GuruFocus, Barchart, Malibu Report, YCharts, Morningstar, and Wallet Investor reported previously on Hummingbird Resources PLC (HUMRF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Hummingbird Resources PLC is an emerging + 100,000 oz gold producer. The Company has successfully built and commissioned its high-grade Yanfolila Gold Project in Mali. Its team has 124 years experience in Africa on 61 projects, an also 143 years operational experience. The Company’s aim is to become a significant mid-tier producer. Established in 2005, Hummingbird Resources is based in London, England.

The Company (since its IPO (Initial Public Offering)) has considerably increased its worldwide resource inventory from an initial 0.8Moz to 6.4Moz throughout two countries, Mali and Liberia. It initially centered most of its resources on the Dugbe Gold Project in Liberia following the low-cost acquisition of Gold Fields’ gold assets in Mali in 2014. The Dugbe Gold Project is the largest known gold deposit in the nation.

Hummingbird Resources has subsequently refocused its attention on the high grade Yanfolila Gold Project. Nonetheless, the Dugbe Gold Project remains an important component of its portfolio. In April 2013, Hummingbird Resources published a positive PEA (Preliminary Economic Assessment). It is presently making progress with its Detailed Feasibility Study (FS).

The Yanfolila Gold Mine is in southern Mali. Yanfolila is a low cost, high grade open pit mining operation. It poured first gold in December of 2017. The Deposit is open on strike and at depth. Expansion is from the Gonka Deposit. There is the potential to boost production, as well as substantial life of mine extension potential.

Additionally, the Company has a 34 percent stake in Cora Gold. Cora has its Sanankoro gold discovery with the potential for a 1Moz+ standalone mine development. Stage 1 drilling is complete at the Sanankoro gold discovery with new targets identified and very encouraging high-grade gold intercepts.

Recently, Hummingbird Resources provided an operational update and announced preliminary production results for Q4 and twelve months ended December 31, 2018 at its Yanfolila Gold Mine in Mali. 91,620 ounces (oz) of gold poured as poured in Fiscal Year 2018, which was at the top end of the revised guidance of 87,000 – 92,000 oz. 17,895 oz of gold was poured in Q4 2018 at an AISC (All-in Sustaining Cost) of US$1,677. The Company stated that it has had a good start to operations this year with production in January on course to produce circa 10,000 oz.

Hummingbird Resources PLC (HUMRF), closed Tuesday's trading session at $0.243, up 21.50%, on 15,000 volume with 3 trades. The average volume for the last 3 months is 8,769 and the stock's 52-week low/high is $0.150000005/$0.430000007.

chart

CTD Holdings, Inc. (CTDH)

HotStockChat, Capital Cube, Dividend Investor, Greenbackers, Wall Street Resources, Marketwired, Pink Investing, YCharts, Nebula Stocks, The Street, 4-Traders, Business Insider, Guru Focus, Penny Stock Hub, Financial Content, Research Pool, Morningstar, Market Screener, and Wallet Investor reported earlier on CTD Holdings, Inc. (CTDH), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter. 

CTD Holdings, Inc. is developing cyclodextrin-based products for the treatment of disease. This includes Trappsol® Cyclo™. The Company’s other divisions distribute and manufacture the trademarked Trappsol® and Aquaplex® cyclodextrins, cyclodextrin derivatives, and cyclodextrin complexes for biotechnology and life science companies engaged in the research, pharmaceutical, medical device, cosmetics, and nutrition markets. CTD Holdings is headquartered in Alachua, Florida.

The Company’s Trappsol® Cyclo™ is an orphan drug designated product. It is for the treatment of Niemann-Pick Type C (NPC). NPC impacts the brain, lung, liver, spleen, as well as other organs. Additional indications for the active ingredient in Trappsol® Cyclo™ are in development. This includes peripheral artery disease, diabetic nephropathy, and acute viral infections.

CTD Holdings’ other divisions operate the world's only cGMP pulse drying facility to produce UltraPure™ cyclodextrin derivatives and pharmaceutical grade Aquaplex® cyclodextrin complexes. Furthermore, they supply cyclodextrins to biotechnology and life science researchers internationally from the world's largest catalog of cyclodextrins.

CTD Holdings has started a multi-center worldwide Phase I/II clinical trial in Europe. This clinical trial is evaluating intravenous administration of Trappsol® Cyclo™ in NPC patients.

CTD Holdings announced in November 2018 its newest partner in support of its U.S. clinical program, Synteract. Synteract is a full-service Clinical Research Organization, which has an existing relationship with CTD in support of its Phase I/II clinical trial at sites in Israel and Sweden. Synteract will support CTD’s Extension Protocol, “An Open-Label Extension Study of the Long-Term Safety and Efficacy of Intravenous Trappsol® Cyclo™ (HPBCD) in Patients with Niemann-Pick Disease Type C (NPC-1),” in the U.S.

Recently, CTD Holdings announced its newest partner in support of its U.S. clinical program, United BioSource LLC (UBC). UBC provides pharmaceutical and home nursing services in support of clinical trials and other patient-centered initiatives. UBC will support CTD’s above-mentioned Extension Protocol.

CTD’s Extension Protocol for the Phase I trial was approved by the Food and Drug Administration (FDA) in April of 2018. The Protocol allows eligible subjects who have completed the Phase I trial in the U.S. to continue to receive intravenous administration of the Company’s Trappsol® Cyclo™, CTD’s proprietary formulation of hydroxypropyl beta cyclodextrin, until market registration.

CTD Holdings, Inc. (CTDH), closed Tuesday's trading session at $0.40, up 17.6471%, on 2,450 volume with 2 trades. The average volume for the last 3 months is 11,488 and the stock's 52-week low/high is $0.300000011/$1.17999994.

chart

Nanophase Technologies Corp. (NANX)

Schaeffer’s, StockEgg, Stealth Stocks, CoolPennyStocks, Wall Street Resources, SmarTrend Newsletters, Investment Contrarians, RedChip, Profit Confidential, BullRally, Stock Rich, HotOTC, and Penny Invest reported previously on Nanophase Technologies Corp. (NANX), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Nanophase Technologies Corp. is a technology leader in nanomaterials and advanced nanoengineered products. The Company provides nanoengineered solutions for numerous industrial product applications. Nanophase assists its customers in succeeding, with proprietary and patent protected technologies. These technologies allow them to create unique products. OTCQB-listed, Nanophase Technologies is based in Romeoville, Illinois.

  Nanophase delivers commercial quantity and quality nanoparticles, coated nanoparticles, and nanoparticle dispersions in a variety of media. The Company produces engineered nanomaterial products for use in an array of markets. These markets include Surface Finishing, Exterior Coatings, Personal Care, Plastics, Scratch Resistant Coatings, as well as Textiles.

Nanophase’s products include Aluminum Oxide, Antimony Tin Oxide, Bismuth Oxide, Cerium Oxide, Iron Oxide, and Zinc Oxide. Nano metal oxides provide UV protection across plastics, exterior coatings, and textile applications. Infrared absorbing particles create high clarity, energy saving films and interlayers.

The Company’s nano and submicron Aluminum Oxide imparts scratch resistance to coatings for wood, laminates, packaging, graphic arts, and electronics. Nano metal oxide technology improves the durability and capacity of zinc anode-based batteries.

Regarding nanoparticle surface treatment, Nanophase Technologies utilizes patented and proprietary particle coating technology to tailor the surface of the nanoparticles by discreetly encapsulating individual particles. The process can be used to impart a broad spectrum of functionality to the particles that, in addition to helping to ensure success in the application, provides the Company’s customers with a considerable deal of flexibility in formulation with the nanoparticles. Nanophase Technologies can provide the products in dry powder or pre-dispersed formats.

Concerning nanoparticle production technology, the traditional and most customary manufacturing methods used at the Company are plasma-based. The Physical Vapor Synthesis (PVS) and NanoArc® Synthesis (NAS) methods use transferred and non-transferred electric arcs to vaporize precursor materials. These are then carefully condensed to produce nanoparticles with desired properties.

Pertaining to Dispersion Technology, the Company has developed dispersed product formats for all of its nanocrystalline metal oxides. These concentrated dispersions are manufactured using an assortment of polar and non-polar organic solvents, water, as well as monomers as the continuous phase. The proprietary chemistry and process technology employed to prepare these dispersions ensures that Nanophase’s customers receive ready-to-use products in which the nanoparticles are stabilized at their primary particle size, with no secondary structure or agglomeration.

Nanophase Technologies Corp. (NANX), closed Tuesday's trading session at $0.53, up 19.1011%, on 10,120 volume with 6 trades. The average volume for the last 3 months is 6,941 and the stock's 52-week low/high is $0.301999986/$1.10000002.

chart

IronClad Encryption Corporation (IRNC)

4-Traders, PennyStockHub, The Street, Simply Wall St, MarketWatch, InvestorsHub, OTC Markets, YCharts, Barchart, Investors Hangout, Stock News Now and TradingView reported earlier on IronClad Encryption Corporation (IRNC), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

IronClad Encryption Corporation is a next-generation cyber defense company headquartered in Houston, Texas. Its strategic and tactical data protection solutions strengthen existing encryption methods. The Company’s technology can provide continuous authentication of encrypted data transmitted, creating much stronger defenses to most hacker attacks. IronClad Encryption lists on the OTC Markets’ OTCQB.

IronClad Encryption-powered solutions use the Company’s patented Dynamic Encryption and Perpetual Authentication technologies to make all known key-based encryption technologies almost impossible to compromise. Dynamic Encryption Technology eliminates vulnerabilities caused by exposure of any single encryption key through continually changing encryption keys and keeping the keys synchronized in a fault-tolerant way.

Dynamic Encryption technology eliminates the single point of failure problem inherent in single-key encryption techniques. IronClad’s key management system continuously produces synchronous keys between the sender and receiver. Each key is assigned to a small amount of data. Therefore, if a hacker were to access one of hundreds of millions of keys, the amount of data he would obtain would be almost useless.

IronClad Encryption has a partnership with Black Pearl Engineering Management, Inc. to co-develop ultra-secure products based on IronClad’s patented ultra-secure cybersecurity algorithms and methodologies. The joint venture (JV) operates under the name "Black ICE". It is initially focusing on network gateway products. BlackICE Barrier is the first product in a family of BlackICE products. BlackICE Barrier is specifically targeted at enterprises and industrial use cases where data and control systems require the highest level of security.

IronClad Encryption offers its ICEMicro. This is the world’s first context-free and natively-secure container. It enables all developers to take ownership of application data security. Employing ICEMicro, any developer can secure communication between containers across varied scheduling and orchestration platforms, IaaS services, transport-layer security protocols, and on-premises or hybrid environments utilizing Docker-compatible hypervisors.

Recently, IronClad Encryption announced that it received notice from the United States Patent and Trademark Office (USPTO) that six of its patents were allowed. The titles of the IronClad patents that have been provided a Notice of Allowance include: Securitization of Temporal Digital Communications with Authentication and Validation of User and Access Devices; User-Wearable Secured Devices Provided Assuring Authentication and Validation of Data Storage and Transmission; and Devices that Utilize Random Tokens Which Direct Dynamic Random Access.

Titles also include: Devices for Transmitting and Communicating Randomized Encrypted Data Utilizing Sub-Channels; Executable Coded Cipher Keys; and Combined Hidden Dynamic Random-Access Devices Utilizing Selectable Keys and Key Locators for Communicating Randomized Data together with Sub-Channels and Coded Encryption Keys.

IronClad Encryption Corporation (IRNC), closed Tuesday's trading session at $0.0104, up 23.8095%, on 5,160,297 volume with 135 trades. The average volume for the last 3 months is 16,072,093 and the stock's 52-week low/high is $0.0057/$0.699999988.

chart

MassRoots, Inc. (MSRT)

Stock News Now, OTCtipReporter, PennyStockScholar, Profitable Trader Authority, SmallCapVoice, Penny Stock 101, CFN Media Group, Wealth Daily, Cannabis Financial Network News, Promotion Stock Secrets, Stock Commander, Damn Good Penny Picks, Penny Picks, OTCJournal, and StockRockandRoll reported earlier on MassRoots, Inc. (MSRT), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter. 

MassRoots, Inc. is a leading technology and rewards platform for medical cannabis patients and businesses. Individuals use its application to share their cannabis experiences and stay connected with local dispensaries. MassRoots has affiliations with the top organizations in the cannabis industry. MassRoots lists on the OTC Markets Group’s OTCQB.

  MassRoots’ product pipeline includes Dispensary Finder & Menus; Product Pages & Reviews; Sponsored Posts 2.0; and Enhanced Profiles. The majority of the Company’s advertising revenue has come from dispensaries and cannabis-brands in the States of California and Colorado.

Businesses can use MassRoots to advertise their goods and services to cannabis consumers.  MassRoots starts adding in features. These include order ahead, delivery, and the in-app purchase of ancillary products as regulations allow.

  In January of 2017, MassRoots acquired DDDigtal, d.b.a. "Whaxy”. This is an online order-ahead and menu management platform. MassRoots has made a strategic investment in High Times Holding Corporation, "High Times", the leading voice of the Cannabis Industry.

MassRoots also acquired Odava, Inc. MassRoots now offers dispensaries a complete set of software to manage their regulatory compliance, streamline their supply chain, and develop successful consumer loyalty programs. Odava is a foremost compliance and point-of-sale (POS) system for the cannabis industry.

Furthermore, MassRoots acquired CannaRegs, Inc. CannaRegs is a top technology platform. It tracks changes in cannabis regulations and taxation at the municipal, state, and federal levels. Moreover, MassRoots created MassRoots Blockchain Technologies, Inc. This is a wholly-owned subsidiary of MassRoots committed to developing blockchain-based solutions for the cannabis industry.

In late December, MassRoots announced that its WeedPass™ rewards system has gained adoption by over 140 dispensary locations since launching in August of 2018. MassRoots is continuing to expand the diversity of rewards offered by WeedPass™ and the markets in which it's available. At present, the Company offers its WeedPass™ rewards program to regulated dispensaries in Denver and Los Angeles. It plans to expand to the San Francisco and Phoenix markets in early 2019. WeedPass™ enables consumers to earn tickets to movies, sporting events, as well as festivals by shopping at participating dispensaries.

MassRoots, Inc. (MSRT), closed Tuesday's trading session at $0.02, up 20.4819%, on 4,100,992 volume with 195 trades. The average volume for the last 3 months is 986,238 and the stock's 52-week low/high is $0.013/$0.240500003.

chart

Lithium Exploration Group, Inc. (LEXG)

MicroCap Daily, Insider Financial, Penny Stock Tweets, Epic Stock Picks, OTC Markets, and The Wolf of Penny Stocks reported on Lithium Exploration Group, Inc. (LEXG), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Lithium Exploration Group, Inc. concentrates on the acquisition and development potential of lithium brines and other precious metals that demonstrate high probability for near-term production. The Company is currently focusing on sales and distribution of the Sonic Cavitation Ltd. technology and the acquisition of oil and gas related assets in the U.S. and Canada. An exploration and development company, Lithium Exploration is based in Phoenix, Arizona.

Lithium Exploration’s commitment is to developing assets and technologies in Oil & Gas, and Waste Treatment. The Company is developing an ultrasonic generator for different field applications in the oil and gas industry. The technology provides lower cost, low energy solutions to many pre-existing processes within these markets.

Lithium Exploration’s Oil & Gas assets consist of the White Top Field. This asset is positioned onshore in Southwest Louisiana.  The cumulative production to-date is 32 million barrels. Current production is 120 barrels of oil per day.

The Company has partnered with Sonic Cavitation (SonCav) to develop SonCav's patented technology for the treatment of hydrocarbon fluid stocks and waste water. The SonCav generator is skid mounted for easy mobility to even the most remote field locations. At present, SonCav is field ready for customers across North America. SonCav runs off of 3 phase electricity. It produces no on-site emissions.

Lithium Exploration announced this past March that its partners in the White Top project were making major progress on the preparations to close on the eventual acquisition of the field and development strategy. The seismic data has been totally processed.

Lithium Exploration stated that it continues to impress all parties that have looked at it. The Company has a royalty interest in the future development of the major oil and gas opportunity in Louisiana.

Lithium Exploration’s Blockchain efforts in the oil and gas industry are moving forward. The Company has been incubating a Blockchain concept, which will make it much easier and more transparent for investors who are not part of the oil and gas ecosystem to participate in investment opportunities.

Nonetheless, the Company is not spending any money on those efforts until after the completion of the royalty acquisition.  Lithium Exploration is looking to partner with a couple of external companies to establish the Blockchain marketplace that it will manage.

Recently, Lithium Exploration announced that preparation and permitting was initiated at its oil project in SW Louisiana. The expectation is that the pad undergoing preparation will host the drilling of the first three target locations.

A joint team of internal and external geophysicists have prepared the locations.  This team has identified these locations in a specific fault block, using the processed seismic data collected last year versus historical production from the field, and determined that these locations will be the most productive. The team has put a projection of 800K to 1.4M barrels of oil from this fault block that can be simultaneously extracted by drilling three wells at different depths. 

Lithium Exploration Group, Inc. (LEXG), closed Tuesday's trading session at $0.0058, up 38.0952%, on 163,856 volume with 10 trades. The average volume for the last 3 months is 169,372 and the stock's 52-week low/high is $0.003/$0.022099999.

chart

Alternative Investment Corporation (AIKO)

OTC Markets, InvestorsHub, MarketWatch, Stockhouse, Equity Base, 4-Traders, Market Exclusive, Simply Wall St, GuruFocus, Wealth Simple, Wallet Investor, Investopedia, TradingView, Stockopedia, Barchart, Stockscores, and Stockwolf reported on Alternative Investment Corporation (AIKO), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Alternative Investment Corporation (AICO) is a real estate development and acquisition organization. The Company’s focus is on properties in the United States and Japan. AICO has developed a signature approach to managing all facets of the development process. This is from property acquisition, financing and design to construction and marketing.

Established in 2007, the Company previously went by the name Paradigm Resource Management Corporation. It changed its name to Alternative Investment Corporation in September of 2015. AICO’s shares trade on the OTC Markets Group’s OTCQB. The Company has its corporate headquarters in New York, New York.

AICO is a full service developer. It has the ability to quickly move any project from site selection, acquisition and financing to construction, leasing, property management and maintenance. AICO chiefly concentrates on distressed real estate assets and/or alternative real estate developments.

The Company’s emphasis is Technological Innovation, Sustainable Design, as well as Adaptive Reuse for contemporary market requirements. Its dedication is to build close relationships with strategic partners, tenants and investors.

The Company’s other businesses include Green Buildings and Technology. Regarding Technology, AICO has invested in technology start-ups, which can be implemented into its development projects.

AICO’s Projects include AICO Plaza. This is in Takarazuka, Japan. AICO Plaza is 5,162.73 square meters. It has 6 residential floors, 4 commercial floors and adjacent parking with 219 parking spaces.

Another of the Company’s projects is Kyoto Plaza. This plaza is in the thousand year capital, Kyoto, the capital city of Kyoto Prefecture in Honshu, Japan. This project is 7280.49373 square feet. The property is 11 floors. This includes a basement level.

Kyoto Plaza is a combination of commercial and residential space. The Plaza offers 4 floors of stores and parking, 5 residential floors, a data center and storage.

AICO also has its Basil and Barns Project. Basil and Barns is on 101 acres of land in Sullivan County. It is two hours north of New York City.

Basil & Barns offers farmhouse villas in an innovative combination of rustic meets upscale resort. Basil & Barns has 30 farmhouse villas. Each of these is 1725 square feet - 2 bed/2 bath. They can convert into 1 bedrooms and studios.

Alternative Investment Corporation (AIKO), closed Tuesday's trading session at $3.25, up 30.00%, on 302 volume with 4 trades. The average volume for the last 3 months is 339 and the stock's 52-week low/high is $0.009999999/$60.00.

chart

The Pulse Beverage Corporation (PLSB)

The Green Baron, Greenbackers, Microcap MarketPlace, Wall St Insider Stocks, Ceocast News, SmallCap Network,  FreeRealTime,  PennyStocksV2, BestStocksDaily, Wall Street Resources, RedChip,  Marketbeat.com, HoleinOneStocks.net, and PennyStockClub reported previously on The Pulse Beverage Corporation (PLSB),  and today we report on the Company, here at the QualityStocks Daily Newsletter.

The Pulse Beverage Corporation is the maker of Natural Cabana® Lemonades, Limeades, and Coconut Waters. It introduced Natural Cabana® Lemonade in 2012. Since that time,  it has developed a multi-national distribution system through more than 155 distributors in 49 U.S. States, Canada, Mexico, Panama, Bermuda, and Ireland.  OTCQB-listed, The Pulse Beverage Corporation is headquarterered in Northglenn, Colorado.

The Company’s aim is to be one of the market leaders in the development and marketing of nutritional/functional beverage products, which provide real health benefits to a large portion of the population and are convenient and appealing to consumers.

  Pulse Beverage’s business model uses warehouse direct and key accounts. The Company has secured greater than 20,000 listings for its Lemonades and Limeades and over 5,000 listings for its Coconut Waters with regional and national grocery and convenience chain stores.

The Company offers Natural Cabana® Lemonade/Limeade in seven, low-calorie flavors.  Additionally,  Pulse  offers Natural Cabana® Coconut Water in pineapple and natural flavors.

  Pulse Beverage teams up with major retailers. These retailers include Walmart, Albertsons/Safeway, Food Max, Kroger, Stater Bros, Houchens, 7-Eleven, United C-stores, Kmart, and Weis Markets. Major retailers also include King Kullen, WinCo Foods, Price Less Markets, Hy-Vee Supermarket, Gristede's Foods, Toot n Totem, and Travel America.

Recently, Pulse Beverage announced that it acquired international distribution for its Natural Cabana® Coconut Waters in the People’s Republic of China (PRC) via its new U.S. based distribution partner, Better4U Food & Beverage, Inc.

Better4U has distribution in the PRC and consumer demand for more than 15,000 cases per month worth a minimum of $450K per quarter in Net Revenues for Pulse. In this partnership, Better4U pays for the product up front. This eliminates the credit risks for Pulse.

Furthermore, in March, Pulse announced that it acquired international distribution for its Natural Cabana® Lemonades & Limeades in the Republic of China (Taiwan) via Better4U Food & Beverage. Better4U has distribution in Taiwan and consumer demand for more than 6,500 cases per month worth a minimum of $200K per quarter in additional Net Revenues for Pulse.

The Pulse Beverage Corporation (PLSB), closed Tuesday's trading session at $0.0001, even for the day, on 850 volume with 2 trades. The average volume for the last 3 months is 6,922,889 and the stock's 52-week low/high is $0.000099999/$0.001099999.

chart

Graphene 3D Lab, Inc. (GPHBF)

OTC Markets, Agora Financial, and Stockhouse reported on Graphene 3D Lab, Inc. (GPHBF),  and today we are highlighting the Company, here at the QualityStocks Daily Newsletter. 

Graphene 3D Lab, Inc.,  via its wholly-owned subsidiary, Graphene Laboratories, Inc.,  develops, manufactures, and markets proprietary graphene-based nanocomposite materials for varied kinds of 3D printing. This includes fused filament fabrication. In addition the Company engages in the manufacture and sale of graphene materials and nanocomposite enhanced polymers through Graphene Laboratories.

Last week, Graphene 3D Lab announced that it completed its facility move to the new industrial facility at 760 Koehler Avenue, Ronkonkoma, State of New York. The 8,000 sq. ft. facility is in a tech park close to Long Island MacArthur Airport. It is approximately 30 miles from Graphene 3D Lab’s former Calverton facility. 

The Company’s go-to-market product is Conductive Graphene Filament. Conductive Graphene Filament brings users the ability to 3D print circuitry and sensors for electronic applications.  Graphene 3D Lab has its Industrial Materials Division to commercialize graphene composite materials. Graphene is a single-layer of carbon atoms. Graphene is considered a wonder-material for its high strength, conductivity, and ultra-light-weight.

Furthermore, Graphene 3D Lab  engages in the design, manufacture, and marketing of 3D printers and related products for domestic and  international customers.  It focuses on the development and commercialization of technologies that improve the capabilities of 3D printing. 

The Company’s 3D printing division provides a suite of specialty fused fabrication filaments.  In addition,  Graphene 3D Lab owns a new proprietary technology encompassing the preparation and separation of graphene's atomic layers. 

Graphene 3D Lab announced in 2017 the commercial release of two new additions to the G6-Epoxy™ product line of advanced adhesive materials. The product line includes unique carbon-silver adhesive materials. These are built on technology that has undergone development by the Company’s Industrial Division. The new epoxies are highly electrically conductive adhesives with a proprietary formula based on the combination of graphene and silver fillers and other additives. 

Graphene 3D Lab has released the Graphene-HIPS 3D Printing Filament. Graphene-HIPS is a distinctly engineered and innovative semi-flexible FDM 3D Printing material reinforced with graphene. The design of it is for high performance 3D printing. The FDM material exhibits premier interlayer adhesion, toughness, and also premier impact resistance.

Recently, Graphene 3D Lab announced it filed a patent application entitled "Method and System for Recovering and Utilizing Heat Energy Produced by Computer Hardware in Blockchain Mining Operations" with the United States Patent and Trademark Office (USPTO). This invention introduces a pioneering new technology for recuperating the thermal energy produced in the computation and Blockchain operation, using that recovered thermal energy in heating and/or refrigeration modules utilizing graphene.

With the method invented by Graphene 3D Lab, the thermal energy produced by the computational hardware is harvested and converted into heating and/or refrigeration solutions with modules utilizing graphene. The solutions can be used for air conditioning or food preservation. Therefore, this lessens electric energy consumption while supporting the Blockchain network or cryptocurrency mining.

Graphene 3D Lab, Inc. (GPHBF), closed Tuesday's trading session at $0.058, up 16.00%, on 7,000 volume with 4 trades. The average volume for the last 3 months is 85,228 and the stock's 52-week low/high is $0.030999999/$0.115000002.

chart

Zoompass Holdings, Inc. (ZPAS)

MarketWatch and InvestorsHub reported on Zoompass Holdings, Inc. (ZPAS), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.

Zoompass Holdings, Inc. is a top financial services technology enterprise headquartered in Toronto, Ontario. The Company is a financial platform provider. It has divisions in physical prepaid cards, financing enablement, as well as mobility products. Zoompass Holdings lists on the OTC Markets Group’s OTCQB.

In January of 2017, the Company received approval from FINRA (the Financial Industry Regulatory Authority, Inc.) to change its name from UVIC, Inc. to Zoompass Holdings, Inc. The Company's ticker was changed to ZPAS from UVVC.

In February of 2017, FINRA approved a 3.5 forward split for shareholders of record on September 7, 2016. Both actions were approved by the majority of shareholders on September 7, 2016.

In the card sector, the Company provides complete program management services for a wide assortment of open loop Visa® and MasterCard® prepaid and virtual card accounts. The Company enables businesses to provide their customers with a number of open loop card choices. These include gift cards, incentive cards, check replacement cards, as well as online virtual card accounts.

Zoompass can support clients’ program management needs, provide turnkey program management services, including program concept, card design, card submission and approval, client portal design and development, administration management, reporting and customer service support.

The Company also provides advanced mobile technology. This enables businesses to provide their customers with a white label mobile wallet solution, such as Zoompass, with the ability to manage their card balances, bill pay, transfer funds, and perform card to card money transfers in real time using their mobile devices.

The Zoompass Platform and the Prepaid Card Solution can be combined with the Company’s Mobile Money technology to transform a business. Zoompass works to guide small to midsize enterprises through payment needs situations, market and organizational assessments, and process requirements, to streamline existing capabilities, identify opportunities, and boost profitability.

Zoompass provides robust financial services virtually through one of the most advanced platforms available. It provides businesses and government tailored solutions to help digitize their financial transactions.

The Company’s platform drives banking independence, personal financial accountability, and new revenue opportunities for small and large businesses. Zoompass’ mobile device division helps carriers and mobile device manufacturers integrate the financial platform technology into their offerings.

Recently, Advanced Credit Technologies, Inc. (CyberloQ) announced it started the integration process with Program Manager, Zoompass and related Banking partners to launch Advanced Credit Technologies’ first Pre-Paid Card platform, the Kingdom Card.

The Kingdom Card combines “FRAUD” mitigation by way of the CyberloQ™ protocol, and “FINANCIAL LITERACY” via the TurnScor credit restoration platform. The Kingdom Card has the capacity to help millions of individuals with financial problems through TurnScor, while protecting their monies with CyberloQ™ fraud protection.

Zoompass Holdings, Inc. (ZPAS), closed Tuesday's trading session at $0.10, up 21.2121%, on 16,610 volume with 4 trades. The average volume for the last 3 months is 25,122 and the stock's 52-week low/high is $0.05/$0.245000004.

chart

North American Nickel, Inc. (WSCRF)

Stockhouse, OTC Markets, YCharts, and Barchart reported on North American Nickel, Inc. (WSCRF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

A mineral exploration company, North American Nickel, Inc. is based in Vancouver, British Columbia. The Company has 100 percent owned properties in Maniitsoq, Greenland and Sudbury, Ontario. It mainly explores for nickel, copper, sulphide, platinum group metals, and cobalt deposits. Incorporated in 1983, North American Nickel lists on the OTC Markets Group’s OTCQB.

North American Nickel employs traditional prospecting methods, modern helicopter-borne, ground and borehole geophysical technologies, and state of the art Worldview-3 satellite imaging, detailed mapping, oriented drill core date and 3D modeling to identify targets and target drill holes.

The Company’s Maniitsoq property in Greenland is a Camp scale project. It consists of 2,985 square km covering manifold high-grade nickel-copper sulphide occurrences associated with norite and other mafic-ultramafic intrusions of the Greenland Norite Belt (GNB).

The greater than 75 km-long belt is positioned along, and near, the southwest coast of Greenland. It is accessible from the existing Seqi deep water port with an all year round shipping season and plentiful hydro-electric potential.

The Maniitsoq project is centered roughly 125 km north of Nuuk, the capital of Greenland. It comprises two, contiguous, Mineral Exploration Licences (registration numbers 2011/54 and 2012/28) located just east of the towns of Maniitsoq and Napasoq.

The Post Creek/Halcyon property is in Sudbury, Ontario. It is strategically situated adjacent to the past producing Podolsky copper-nickel-platinum group metal deposit of KGHM International Ltd.

The Post Creek property comprises 39 unpatented mining claims encompassing a region of 912 hectares. The Halcyon property comprises 53 unpatented mining claim units totaling 864 hectares.

Recently, North American Nickel reported that assays were received from seven drill holes and one drill hole extension completed to test targets at Fossilik and the Imiak Hill Complex (IHC) on its 100 percent owned Maniitsoq nickel-copper-cobalt-PGM sulphide project in southwest Greenland. Hole MQ-17-153 intersected numerous zones with elevated nickel values at the P-004 target area within the large Fossilik intrusion.

During the 2017 exploration program, 23 drill holes totaling 8,767 meters were completed to test mineralized zones and geophysical targets in the IHC, Fossilik and P-013 SE areas within the Greenland Norite Belt.

The Fossilik area is in the central portion of the Greenland Norite belt. The Imiak Hill Complex is 8 km north of Fossilik. It consists of the Mikissoq, Imiak Hill and Spotty Hill sulphide zones.

North American Nickel, Inc. (WSCRF), closed Tuesday's trading session at $0.015, up 50.00%, on 25,000 volume with 2 trades. The average volume for the last 3 months is 7,203 and the stock's 52-week low/high is $0.006/$0.058030001.

chart

Integrated BioPharma, Inc. (INBP)

StockMister, OTCPicks, HotShotStocks, Wall Street Mover, Zacks, The Stock Psycho, Top Gun, and AllPennyStocks reported earlier on Integrated BioPharma, Inc. (INBP), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Integrated BioPharma, Inc. engages primarily in the manufacture, distribution, marketing, and sales of vitamins, nutritional supplements, and herbal products. Its customers are mainly in the United States, Luxembourg, and Canada. Integrated BioPharma develops, manufactures, and distributes, around the world, in excess of 130 products. The Company does so through several wholly-owned subsidiaries.

Integrated BioPharma formerly went by the name Integrated Health Technologies, Inc. Established in 1979, the Company is based in Hillside, New Jersey. Integrated BioPharma lists on the OTC Markets.

Integrated Biopharma’s companies include AgroLabs, Inc., Chem International, IHT Health Products, Inc., Manhattan Drug Company, and Vitamin Factory. Integrated BioPharma operates via three segments. These are Contract Manufacturing, Branded Proprietary Products, and Other Nutraceutical Businesses.

AgroLabs manufactures and markets healthful nutritional products under the Naturally Noni, Naturally Pomegranate, Naturally Aloe, and Naturally Mangosteen brands. Additionally, AgroLabs distributes internationally, in Canada, Germany, Japan, Korea, Mexico, Taiwan and the United Kingdom (UK). Integrated BioPharma’s Chem International offers a broad assortment of Roche Vitamins' food and cosmetic products.

The Company’s Contract Manufacturing segment manufactures vitamins and nutritional supplements for sale to distributors, multilevel marketers, and specialized health-care providers. Its Branded Proprietary Products segment distributes healthful nutritional products for sale through mass market, grocery, drug, as well as vitamin retailers.

The Other Nutraceutical Businesses segment sells private label vitamin and nutritional supplement products, and healthful nutritional products through the Internet. In addition, this segment distributes fine natural botanicals. This includes multi minerals and raw materials. Moreover, the Other Nutraceutical Businesses segment provides warehousing and fulfilment services.

Integrated BioPharma’s Vitamin Factory sells nutritional supplements directly to the consumer by way of mail order catalogs and over the Internet. Vitamin Factory’s product categories are dietary supplements, liquid items, sports supplements, and skincare supplements.

Manhattan Drug Company provides vitamins and nutritional formulations. It engages in the manufacturing of tablets, capsules, or blends; packaging and labeling in bulk; help in product registration worldwide, and distribution of finished product. Also, Manhattan Drug Company engages in analytical and microbiological testing via its in-house laboratories.

Integrated Biopharma’s IHT Health Products sells and distributes fine chemicals. These include science-based proprietary products and value added formulations. IHT sells and distributes these to the nutritional, pharmaceutical, food, and cosmetic industries. IHT products include vitamins, amino acids, herbal extracts, Over-the-Counter (OTC) pharmaceuticals, excipients, and unique patented products.

Integrated BioPharma, Inc. (INBP), closed Tuesday's trading session at $0.222, up 20.00%, on 500 volume with 1 trade. The average volume for the last 3 months is 10,946 and the stock's 52-week low/high is $0.1008/$0.250999987.

chart

The QualityStocks Company Corner

Endonovo Therapeutics Inc. (ENDV)

The QualityStocks Daily Newsletter would like to spotlight Endonovo Therapeutics Inc. (ENDV).

As part of its goal to reduce post-operative drug dependence, innovative biotechnology company Endonovo Therapeutics (OTCQB: ENDV) recently revealed plans to get its flagship SofPulse Therapy Device into 600 hospitals within the next 18 months. To view the full article, visit: http://nnw.fm/4C8Jq.

Endonovo Therapeutics Inc. (ENDV) develops, manufactures and distributes evolutionary medical devices focused on the rapid healing of wounds and reduction of pain, edema and inflammation on and in the human body. These wearable, non-invasive medical devices are designed to deliver the company’s proprietary, patent protected Electroceutical™ Therapy targeting inflammation, cardiovascular diseases, chronic kidney disease and central nervous system (“CNS”) disorders.

In accord with its mission to transform the field of medicine through innovation, Endonovo’s bioelectric Electroceutical™ devices harness bioelectricity to restore key electrochemical processes that initiate anti-inflammatory processes and growth factors in the body necessary for healing to rapidly occur. Endonovo’s current portfolio of commercial-stage devices address chronic kidney disease, liver disease non-alcoholic steatohepatitis (NASH), cardiovascular and peripheral artery disease (PAD), and ischemic stroke.

Flagship Therapy

SofPulse® Electroceutical ™ Therapy is an easy-to-place, non-invasive device that delivers pulsed electromagnetic frequencies to enhance post-surgical recovery. Used as a stand-alone therapy or integrated into any treatment protocol, SofPulse®’s?targeted?pulsed electromagnetic field?(tPEMF)?transmits gentle pulses to the tissue causing a positive biological effect to help reduce swelling and accelerate the body’s natural recovery process. The low levels of electromagnetic fields are completely safe and are 1000 times lower than those emitted by a mobile phone.?

Because SofPulse® lessens the pain of post-surgical recovery, the patient requires far less prescription medications, thereby minimizing or eliminating the adverse side effects of narcotics and anti-inflammatory medication. Studies have shown a greater than 2.2-fold reduction in narcotic use over the first 48 hours post-procedure. Patients with less pain and medication may move around sooner, which further stimulates the body’s natural response to healing.

Certifications

Endonovo’s Electroceutical™ Therapy is cleared by the U.S. Federal Drug Administration (“FDA”) for the palliative treatment of pain and post-surgical edema (swelling) and is CE-marked in the European Economic Area (“EEA”) for the promotion of wound healing and the palliative treatment of pain and post-surgical edema. The Centers for Medicare and Medicaid Services (“CMS”) has also certified Electroceutical™ Therapy for the treatment of chronic wounds.

Management

Alan Collier, Chairman and CEO
Alan Collier has more than 25 years of experience in corporate finance, IP development, telecommunications and technology, with a concentration in healthcare and technology over the past five years. Collier has served as CEO and director of IP Resources International Inc., where he was instrumental in developing a platform the for the licensing and acquisition of life science and technology companies. He has held numerous board and executive positions throughout his career in the telecommunications, technology, specialty finance, corporate finance and healthcare industries. Collier has previously held FINRA Series 7, 79, 63 and 24 licenses.

Michael Scott Mann, President
Michael Scott Mann has over 30 years of experience in merger and acquisitions and operational management. In 2008, Mann acquired the assets of Hanover Asset Management, now Endonovo Therapeutics Inc., and led the company to become listed on the OTCBB in 2012. He was the founder, president and CEO of Frankfurt-listed U.S. Debt Settlement Inc. (USDS), where he implemented a growth by acquisition strategy.?

Don Calabria, Chief Operating Officer
Don Calabria has over 20 years of leadership and experience in national business operations to emerging growth companies, mergers and acquisitions, finance and business development. Calabria holds an MBA from the Graziadio School of Business and Management at Pepperdine University and a bachelor’s degree from Arizona State University.

Nevena Zubcevik, Chief Medical Officer
Nevena Zubcevik, D.O., MSPT, ATC, on July 1, 2019, will lead Endonovo’s medical and clinical strategy, including the development and regulatory matters and new business development. Zubcevik, a licensed physician and educator, has more than 24 years of experience in the medical field and was an attending physician at Harvard Medical School/Partners Healthcare in the physical medicine and rehabilitation department.

Steven Ford, Vice President of Marketing
Steven Ford has 25 years of experience in the field of medical devices, including experience in sales management, product management, product development, business development and research & development at companies such as Baxter, CR Bard, Ethicon, Allergan, Mallinckrodt Pharmaceuticals and Alphatec Spine. Throughout Ford’s career, he has led and participated on over 75 product development teams and has launched over 50 medical devices globally. Ford is an innovative problem solver and has many patents in the areas of hemostasis, sealing and tissue reconstruction. Most recently, Steve was the U.S. vice president of marketing for Biom’up where he was a co-lead on the high-profile successful launch of their surgical hemostat HEMOBLAST Bellows. Steve holds a bachelor’s degree in marketing from California State University.

David Clark, Vice President of Sales
David Clark has extensive surgical device commercial experience which includes 25 years in the surgical device industry with leading companies including Medtronic and Baxter Healthcare. Most recently, Clark was the U.S. executive vice president of sales for Biom’up where he was a co-lead in the high-profile successful launch of their surgical hemostat HEMOBLAST. As part of the launch, he built and led the U.S. sales team which included over 200 in-direct sales representatives and direct commercial leadership. During his 15 years with Baxter, the BioSurgery Division grew from a small revenue business into a major market player in the advanced hemostasis space with products such as FloSeal and Tisseel. Clark has a bachelor’s degree in economics from Rutgers University.

Roc Alan McCarthy, Scientific Advisory Board Member
Roc Alan McCarthy, D.O, will help Endonovo continue to advance its clinical pipeline and contribute to the strategic and clinical development oversight of the company. McCarthy is a urologist in North Carolina, currently serving as the robotic surgeon and chairman of the robotics committee at the New Hanover Regional Medical Center.

Endonovo Therapeutics Inc. (ENDV), closed Tuesday's trading session at $0.017, up 4.94%, on 2,966,812 volume with 65 trades. The average volume for the last 3 months is 5,338,022 and the stock's 52-week low/high is $0.009/$0.066100001.

Recent News

chart

Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP)

The QualityStocks Daily Newsletter would like to spotlight Lexaria Bioscience Corp. (LXRP).

Lexaria Bioscience Corp.’s (CSE: LXX) (OTCQX: LXRP) new enhanced version of its patented delivery technology, DehydraTECH, has demonstrated that it can deliver eight-times more CBD into the blood and 19-times more CBD into the brain tissue than standard industry formulations. These results were confirmed in clinical lab tests conducted with live animals. LXRP has filed new patent applications based on these innovations (http://nnw.fm/bXV3l).

Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP) has developed and out-licenses its proprietary technology for improved taste, rapidity, and delivery of bioactive compounds, including nicotine and cannabinoids. To achieve higher absorption rates and fast onset, consumers traditionally defaulted to smoking. Lexaria provides a superior administration method by delivering these substances through a patented process within edible food products, thus eliminating all the harmful health consequences of smoking.

Lexaria’s technology is unique in that it takes advantage of GRAS (Generally Recognized As Safe) food ingredients processed with its patented DehydraTECHTM technology to improve taste, remove odor, and decrease the time to onset of bitter-tasting drugs. Lexaria is primarily a B2B enterprise and has existing cannabinoid licensing agreements with companies in Canada, the largest-market states in the United States, and internationally. Lexaria has entered into a R&D partnership with one of the largest cigarette companies in the world for oral forms of nicotine delivery. Lexaria has also developed its own brands partly for demonstration purposes, utilizing its patented technology to infuse hemp oil ingredients within popular foods such as coffee, tea, and supplements. These brands include ViPova™ and TurboCBD™.

In 2015, Lexaria commissioned an independent third-party lab to test its technology under carefully monitored in vitro conditions. Results showed that the company’s technological process and lipid formulation improve intestinal absorption as much as 500%. Lexaria has conducted multiple rounds of studies including in vivo and human clinical. In absorption studies conducted on rats, for example, Lexaria detected nicotine in the animal’s bloodstream just two minutes after it entered the stomach. In a randomized, double blinded human clinical study, cannabidiol (CBD) was measure in the human bloodstream at a 317% higher rate 30 minutes after swallowing a capsule processed with DehydraTECH than a non-enhanced capsule of equal strength.

Lexaria also has an R&D partnership with the Canadian government’s National Research Council. That R&D is expected to characterize molecular bond formation theorized to occur with Lexaria’s unique technology between the lipid delivery agents and the bioactive substances it processes and combines. Results from this R&D have helped support B2B relationships with Fortune 500 companies. Lexaria has four distinct subsidiaries that focus on different market sectors: Hemp/CBD; Pharmaceutical; Cannabis; and Nicotine.

Aside from testing, a critical component of Lexaria Bioscience’s business model is a strong and growing intellectual property portfolio. As of the end of 2018, the company’s patent portfolio includes 53 patent applications filed and pending in more than 40 countries around the world; and 10 patents granted to date. Lexaria is expecting additional new patent awards both in the U.S. and internationally in 2019 and beyond. Some of its more recent areas of investigation have included human hormones and erectile dysfunction substances, among others.

Royalties play a vital role in Lexaria’s revenue-generating business model. The company out-licenses its technology (royalty) to third-partners and has signed royalty deals with start-up companies as well as with a Fortune 100. The company’s growth initiatives are guided by a management team headed by CEO Chris Bunka, a serial entrepreneur who has contributed to several multi-hundred million-dollar valuations over the course of his career. He is supported by a growing team of professionals with extensive experience in pharmaceutical and bioscience sectors, invention, toxicology, consumer goods, and other relevant skillsets.

Lexaria Bioscience Corp. (LXRP), closed Tuesday's trading session at $0.8742, up 1.65%, on 60,057 volume with 65 trades. The average volume for the last 3 months is 86,001 and the stock's 52-week low/high is $0.75/$2.24.

Recent News

chart

Marijuana Company of America Inc. (MCOA)

The QualityStocks Daily Newsletter would like to spotlight Marijuana Company of America Inc. (MCOA).

Marijuana Company of America Inc. (MCOA) today announced that the Company’s manufacturing and distribution facility for its Viva Buds cannabis delivery service is expected to be completed and fully functional by August 2019. MCOA announced in April that it had acquired a 20% ownership interest in Natural Plant Extract of California (“NPE”) to establish a joint venture to create Viva Buds Inc., a unique cannabis delivery service based in Los Angeles, California. Also today, the company was highlighted in a publication from Financialnewsmedia.com, examining how, as more jurisdictions have approved medicinal uses of cannabis, many of them have followed with approval of consumer recreational uses… and more food & other consumer CBD infused products are increasingly on the rise as well.

Marijuana Company of America Inc. (OTC: MCOA) (the “Company”) are pioneers in the cannabis industry going back to 2009 when Don Steinberg, MCOA’s CEO, founded the first marijuana company ever to trade on a U.S. stock market, Medical Marijuana Inc. Since then, Don and his partner, Charlie Larsen, have formed Global Hemp Group and Marijuana Company of America. They have experienced the shift of legislation first hand, not only for the legalization of marijuana but also the emerging hemp-based CBD products.

The CBD market is growing exponentially and consequently the founders of MCOA have constructed their business model around the development of industrial hemp-based CBD products. The industrial hemp plant can be used to produce products that are carbon neutral or even carbon negative. It is one of the longest, strongest natural fibers on earth, used as a building material that is free of mold, pesticide-resistant, and fire proof. Hemp has also been described as a “super food,” which provides additional business opportunities. No part of the plant is left unused and the Company’s overall strategy is to take advantage of every profit center from farm to the multiple valuable finished products.

The cannabis and hemp industries are experiencing unprecedented growth that is expected to continue for many years as these industries are now accepted globally and continue to mature and expand. North American consumers spent $6.7 billion on legal cannabis products in 2016, up 34% from 2015’s $5 billion. This trend is widely expected to explode at a 27% compounded annual growth rate to reach $22.6 billion by 2021, according to ArcView Market Research.

The company offers investors the opportunity to be on the forefront of cannabis and hemp innovation through cultivation, processing in the legal cannabis and industrial hemp sectors. The Company’s business model includes producing a diverse portfolio of synergistic business segments that provide value to its shareholders. Its vertically integrated business model and distribution platforms are positioned to capture market share by developing recognizable and valuable brands.

Under the MCOA umbrella, wholly owned subsidiary hempSMART™, Inc. is committed to bringing high quality CBD-based products to the market through its affiliate marketing program. Through hempSMART, MCOA’s strategic approach to the distribution of products is through a networking architecture geared to maintain customer loyalty and capture market share. The patent-pending product “hempSMART Brain,” is designed to revolutionize the safe and effective support of healthy brain function. The brand new product, HempSMART DROPS, is a full-spectrum CBD tincture formulated with hemp and fractionated coconut oils. The hempSMART marketing team has decades of experience, and is well positioned to take the hempSMART brand to a global audience.

Marijuana Company of America Inc. (MCOA), closed Tuesday's trading session at $0.0106, up 2.90%, on 8,087,316 volume with 190 trades. The average volume for the last 3 months is 7,815,828 and the stock's 52-week low/high is $0.009999999/$0.0425.

Recent News

chart

Redfund Capital Corp. (CSE: LOAN) (OTCQB: PNNRF) (FF: O3X4)

The QualityStocks Daily Newsletter would like to spotlight Redfund Capital Corp. (PNNRF).

Redfund Capital (CSE: LOAN) (OTC: PNNRF) (Frankfurt: O3X4) this morning announced its entry into an agreement for the right to acquire 51 percent of Wahupta Ventures Inc. of British Columbia, a Canadian hemp company, staking its position in the CBD sector. Per the update, Redfund has secured the right to purchase 19.9 percent of Wahupta, and will have the option on an additional 31.1 percent upon completion of the due diligence process and the signing of a definitive agreement no later than October 1, 2019. To view the full press release, visit: http://nnw.fm/5qYlY.

Redfund Capital Corp. (CSE: LOAN) (OTCQB: PNNRF) (FF: O3X4) is a merchant bank focused on providing debt and equity funding in the mid to late stages of a target company’s development and for technologies that are developed and validated by revenues. Redfund’s current focus is on medical cannabis, hemp and cannabidiol (CBD) related and healthcare-related companies.

As the first medical cannabis incubator and accelerator financing medical cannabis, CBD and hemp companies through a debt facility, Redfund is effectively bridging finance gaps and helping revenue-producing medical cannabis-related companies grow and build their valuations without prematurely diluting their equity.

The central components of the company’s business strategy are:

  • Establishing the foundation of a loan portfolio that generates revenues through monthly interest income from loans to cover all general and administrative expenses related to day-to-day operations.
  • Growing shareholder value by converting all or part of loans and warrants into equity in portfolio clients as clients build their valuations by entering the public markets or becoming the high-priced targets of larger entities.

Redfund was designed by bankers and entrepreneurs possessing years of experience in business, consulting, capital markets, corporate finance and healthcare services. The company is actively looking beyond borders and creating global companies that have strong fundamentals and are ready to expand.

Redfund’s investments are deployed to companies that have demonstrated success in their business but need a capital bridge in order to expand. Redfund’s team of professionals vet every project and analyzes each prospective client’s financials and business plans. Once a project is approved, Redfund’s legal team carefully scrutinizes the collateral used to securitize the individual loans.

The strategy employed by Redfund includes:

  • Diversifying investments in Canada and other countries
  • Building an international footprint with established national leaders
  • Funding new drug delivery systems and helping nutraceuticals become mainstream drugs
  • Introducing companies to Canada as a viable option for public listings
  • Becoming a premier go-to lender for established companies

The company’s revenue sources include:

  • Interest-bearing debt instruments with asset-backed collateral to securitize loans
  • Equity kicker of warrants coverage on original loan
  • Conversion ability of loan in its entirety
  • Advisory fees from contracts for consulting on growth strategies
  • Right of first refusal on future financing in each company funded

Redfund Capital Corp. (OTCQB: PNNRF), closed Tuesday's trading session at $0.10, up 7.54%, on 300 volume with 1 trade. The average volume for the last 3 months is 843 and the stock's 52-week low/high is $0.089299999/$0.504999995.

Recent News

chart

Petroteq Energy Inc. (TSX.V: PQE) (OTCQX: PQEFF)

The QualityStocks Daily Newsletter would like to spotlight Petroteq Energy Inc. (PQEFF).

Petroteq Energy (TSX.V: PQE) (OTC: PQEFF), an oil and gas industry technology innovator, today announced its entry into a non-exclusive technology licensing agreement with Katy, Texas-based Valkor LLC (www.Valkor-Offshore.com). According to the update, the agreement grants Valkor the right to use Petroteq’s proprietary patented technology to construct, operate and finance oil sands extraction plants to transform mining operations-recovered highly oil saturated feed ore to heavy crude. To view the full press release, visit: http://nnw.fm/pRPo6.

Petroteq Energy Inc. (TSX.V: PQE) (OTCQX: PQEFF) is a Canadian-registered, publicly traded company engaged in the development and implementation of proprietary technologies for the environmentally safe extraction of heavy oils from oil sands, oil shale deposits and shallow oil deposits. The company is focused on oil sands exploration and production on mineral leases in Vernal, Utah, and in expanding production capacity at its Asphalt Ridge heavy oil extraction facility in Utah.

Petroteq Energy’s patent-pending application is a closed-loop, solvent-based process, which results in significantly lower per-barrel production costs than those incurred with traditional hot water-based oil sands extraction technologies. This green technology utilizes a small, modular footprint, produces no greenhouse gases, requires no high temperatures, leaves only clean dry sand, and could be deployed to unlock heavy oil deposits located around the world.

The Company’s Asphalt Ridge mineral lease on 2,500-plus acres in northeastern Utah features a large contingent oil sands resource base with an estimated 87 million barrels of oil equivalent. In 2015, the company produced 10,000 barrels of oil from the Utah location and plans to increase production are underway. Utah holds over 32 billion barrels of undeveloped oil sands resources, which are also known as “oil-wet” deposits containing a mixture of sand and a dense, extremely viscous form of petroleum referred to as bitumen or tar. A recent upswing in developing domestic energy sources has intensified interest in technological advances such as Petroteq’s Clean Oil Recovery Technology (CORT) System.

The Company continues to evaluate the development of other medium to heavy oil exploration, production and recovery projects on a global basis through a variety of structured agreements. These opportunities or other arrangements with private and governmental entities that utilize Petroteq Energy’s proprietary licensed technologies are expected to generate a significant return on investment.

The Company’s management team, board of directors and officers form an invaluable cross-section of industry leaders with extensive experience ranging from chemical engineering and solvent research, business development, international project management, entrepreneurial achievements, and senior management for global energy companies in North America and the Middle East. This impressive knowledge base covers both conventional and unconventional oil and gas projects and production, both in upstream and downstream industry sectors.

Petroteq Energy is also participating in a blockchain initiative aimed at solving the global transaction needs of the oil and gas industry through the development of PetroBLOQ. PetroBLOQ recently joined the Enterprise Ethereum Alliance (“EEA”), the world’s largest open-source blockchain initiative. Membership with the 200-member EEA represents a wide variety of industries and offers 14 industry-focused, member-driven working groups.

“Joining this community of forward-looking enterprises and blockchain innovators is an important step for PetroBLOQ as we develop transformative solutions for the oil and gas industry,” said Petroteq Energy Chairman Alex Blyumkin.

In addition, Petroteq has joined the American Petroleum Institute (API). The API is the only national trade association representing all facets of the oil and natural gas industry, promoting safety across the industry globally and influencing public policy in support of a strong, viable oil and natural gas industry.

“API has led the development of operating standards for our industry, and we look forward to contributing our experience with oilfield technologies in addition to introducing our PetroBLOQ platform to its members throughout the supply chain,” Blyumkin previously stated.

Petroteq Energy Inc. (PQEFF), closed Tuesday's trading session at $0.2352, up 2.26%, on 491,612 volume with 122 trades. The average volume for the last 3 months is 246,926 and the stock's 52-week low/high is $0.207000002/$1.42999994.

Recent News

chart

Sproutly Canada, Inc. (OTCQB: SRUTF) (CSE: SPR) (FRA: 38G)

The QualityStocks Daily Newsletter would like to spotlight Sproutly Canada, Inc. (SRUTF).

Sproutly Canada Inc. (CSE: SPR) (OTCQB: SRUTF) (FRA: 38G) has reached another milestone by successfully completing the first run of the proprietary Aqueous Phytorecovery Process (“APP”) extraction technology licensed from Infusion Biosciences Inc., Sproutly CEO and Director Keith Dolo announced in a news release (http://nnw.fm/z0NRr).

Sproutly Canada, Inc. (OTCQB: SRUTF) (TSX.V: SPR) (FRA: 38G) is developing and bringing to market cannabis consumer products with a focus on beverages. The company’s core mission is to become the leading supplier of water-soluble cannabis solutions and bio-natural oils for brands in the emerging cannabis beverage and edibles market.

To make this happen, Sproutly acquired Infusion Biosciences to bring to market a patent-pending Aqueous Phytorecovery Process (APP) technology, a fundamental paradigm shift within the cannabis industry. Replacing traditional water-compatible solutions with true natural water solubility improves the body’s ability to utilize cannabinoids, making the effect of the cannabis almost immediate.

This revolutionary process doesn’t alter the cannabis compounds and provides an onset time and offset time that mimics the same effects as inhaled marijuana. That means consumers may feel effects in five minutes or less and be free from the desired effect in approximately 90 minutes—a vastly different ingestion pattern than current methods. In addition, the water-based cannabinoids can be mixed with other liquids and stay dissolved in those liquids. The application of water-soluble cannabis infusions has potential to be widespread in both medicinal and recreational cannabis sectors, giving Sproutly a distinctive edge in a market with untapped potential.

Sproutly’s business model is focused on processing rather than cultivating, which means its success is not constrained to growing its own cannabis. The company does own a Toronto-based, ACMPR-licensed facility designed and built with a focus on cultivating pharmaceutical-grade cannabis to produce and formulate the first natural, truly water-soluble cannabis solution. Its water-soluble ingredients and bio-natural oils will deliver revolutionary brands to international markets that are searching for well-defined commercial products.

Sproutly’s entrance in the cannabis market is perfectly timed as cannabis is moving towards mainstream acceptance. Potential users are, however, interested in consuming cannabis products as drinks and using it as oils rather than smoking. The potential cannabis beverage market is staggering, and with Sproutly owning the exclusive rights to APP technology in Canada, Australia, Jamaica, Israel and the entire European Union, the company is looking at significant international expansion opportunities.

Sproutly plans to capitalize on these international opportunities by executing on partnerships with local and globally established consumer brands to leverage their existing customer bases, expand brand loyalty, and assist with marketing and support distribution networks to deliver scientific breakthroughs with speed and efficiency?worldwide.

Management

Sproutly believes that talent drives growth. The company is committed to bringing together the best and brightest minds in the cannabis space to help with their mission to disrupt the global beverage and consumables market.

President, CEO and Director Keith Dolo recently served for more than 13 years with Robert Half, an S&P 500, NYSE-listed company. At Robert Half, Dolo held the position of vice president for more than eight years, as well as other senior roles in both operations and sales. He also sits on an advisory committee and a board position for two nonprofits in Vancouver, BC.

Chief Science Officer and Director Dr. Arup Sent has more than 35 years of experience in research and executive management at biotechnology and pharmaceutical companies. He was awarded a PhD in biochemistry from Princeton University and is a former faculty member at the National Cancer Institute and Scripps Research Institute. Sen is the inventor on five U.S. patents and numerous international patents and patent-pending applications.

Chief Financial Officer Craig Loverock is a chartered professional accountant with over 20 years of experience in accounting and finance roles in Canada, the United States and the United Kingdom. He has extensive expertise in public company reporting and transactional experience, having served as the senior financial advisor to the chairman at Magna International and acting as chief compliance officer and CFO for a private equity firm.

Head Grower Frank Han has over 12 years of experience in the horticulture industry. A previous master grower in a large commercial facility, Han has impressive expertise in all growing methods, techniques and procedures. He brings with him a wealth of knowledge in cloning, nutrient and overall plant management. Han will be in charge of the production team at Sproutly’s Toronto Herbal Remedies facility.

Sproutly Canada, Inc. (OTCQB: SRUTF), closed Tuesday's trading session at $0.5170, up 1.84%, on 89,461 volume with 51 trades. The average volume for the last 3 months is 662,396 and the stock's 52-week low/high is $0.189099997/$1.875.

Recent News

chart

VIVO Cannabis Inc. (TSX.V: VIVO) (OTC: VVCIF)

The QualityStocks Daily Newsletter would like to spotlight VIVO Cannabis Inc. (VVCIF).

VIVO Cannabis Inc. (TSX.V: VIVO) (OTC: VVCIF) was featured today in the 420 with CNW by CannabisNewsWire. As Canadians countdown to the start of cannabis edibles sales in December, some sobering information is filtering in to the effect that life insurance premiums could go up depending on one’s cannabis edibles consumption habits.

VIVO Cannabis Inc. (TSX.V: VIVO) (OTC: VVCIF) is a globally licensed, cost efficient producer of premium quality, organic, standardized medicinal cannabis. One of the earliest licensed medical marijuana producers under Canada’s federally-controlled Access to Cannabis for Medical Purposes Regulations (ACMPR), VIVO has five years of operating experience in the burgeoning medical marijuana space through its flagship operation, ABcann Medicinals, Inc. The company recently received its Health Canada license to produce medical cannabis oils and is working toward production of saleable, extracted, finished products that will lead to a final inspection allowing sales of its oils.

“Receipt of the license to produce cannabis oils is a major milestone in our pursuit to provide our medical cannabis patients with additional product formats that can be precisely dosed. The expansion and innovation of our product lines are a top priority for the Company as we continue to serve the needs of our customers, and we anticipate strong demand for our cannabis oil products,” VIVO CEO Barry Fishman said.

VIVO owns and operates a fully functioning 14,500 square foot facility in Napanee, Ontario, which is being doubled in size to produce 1,400 kg of cannabis per year. The company’s expansion plans include adding a seasonal greenhouse and a hybrid, multipurpose facility, capable of producing 31,000 kg of cannabis per year between the two facilities, to be constructed on 65 acres it already owns near the Napanee facility. This additional location is properly zoned with existing infrastructure in place for an eventual 1.2 million square feet of production space.

VIVO has built a reputation over the years for its best-in-class standardized approach to growing cannabis that includes the absence of pesticides and a computer monitored growing technique that provides a consistent, pharmaceutical-grade with high yields. The company’s custom, scalable growing chambers with proprietary lighting can be replicated anywhere in the world, leading to lower production costs. This technique has helped it record a customer retention rate of 94.7 percent alongside 30 percent month-over-month customer growth. When combined with VIVO’s current yield rate, which it has measured at roughly 100 percent greater than the industry average, the company has constructed a strong foundation upon which to build a sizable presence in the global cannabis industry.

This global growth potential is illustrated by VIVO’s partnership with Israel’s Syqe Medical, producer of the world’s first selective-dose pharmaceutical grade medicinal plant inhaler. After visiting VIVO’s production facility, Perry Davidson, founder of Syqe Medical, noted that the company’s production technologies put it “in a class with the best in the world” in its ability to produce standardized pharmaceutical grade cannabis.

VIVO’s recent acquisition of Harvest Medicine Inc. represents further progress toward the company’s goal of becoming a vertically integrated medical cannabis company. Harvest Medicine is one of the fastest growing medical cannabis clinics in Canada – adding over 1,200 new patients monthly from a single location – with an aggressive expansion plan and a patient-focused approach that perfectly aligns with VIVO’s philosophy of quality and innovation.

VIVO’s seasoned management team, board of directors and advisory board features well over a century of combined industry experience. Fishman, who has over 20 years of experience as a business leader, previously served as CEO of both Teva Canada and Taro Canada, as vice president of marketing at Eli Lilly Canada, and as past chair of the Canadian Generic Manufacturers Association. He most recently served as CEO of international specialty pharmaceutical company Merus Labs.

Notably, VIVO also has access to the ‘Father of Cannabis Research’, Raphael Mechoulam, PhD, through its board of advisors. An organic chemist and professor of medicinal chemistry at the Hebrew University of Jerusalem, Mechoulam was the first scientist to isolate both cannabidiol (CBD) and tetrahydrocannabinol (THC). He has received more than 25 prestigious academic awards, including the Rothschild Prize in Chemical Sciences and Physical Sciences in 2012.

With more than 65 acres of growth capacity, a healthy cash balance to fund upcoming construction efforts, steady sales growth, industry-leading yield rates and an established operations team in place, VIVO is well positioned to compete in the rapidly expanding Canadian cannabis industry and beyond.

VIVO Cannabis Inc. (VVCIF), closed Tuesday's trading session at $0.46, up 1.14%, on 299,712 volume with 123 trades. The average volume for the last 3 months is 223,106 and the stock's 52-week low/high is $0.330000013/$1.52999997.

Recent News

chart

TransCanna Holdings Inc. (CSE: TCAN) (FRA: TH8)

The QualityStocks Daily Newsletter would like to spotlight TransCanna Holdings Inc. (CSE: TCAN).

TransCanna Holdings Inc. (CSE: TCAN) (FRA: TH8) was featured today in the 420 with CNW by CannabisNewsWire. When recreational marijuana was legalized in October 2018, most insurance companies stopped regarding marijuana users as smokers. People who are categorized as smokers can pay up to four times more in life insurance premiums when compared to those who are categorized as non-smokers. This is because smokers are seen as being higher-risk clients for insurance companies.

TransCanna Holdings Inc. (CSE: TCAN) (FRA: TH8) brings together a rapidly growing portfolio of cannabis and hemp-related brands and services, with a closed-loop ecosystem approach rooted squarely in the company’s ownership of a 196,000-square-foot, vertically integrated facility in California. The company has developed a two-year, four-phase plan aimed at developing proprietary brands and creating a self-contained ecosystem that ensures reliability, consistency, quality and scale.

Ecosystem

TransCanna’s cannabis facility in Modesto, California, is strategically located less than a three-hour drive from the majority of all major cities in the state. The tri-level building provides internal control of everything needed for the seed-to-sale cycle, from growing and manufacturing to extraction, bottling, transportation and distribution. The facility, which recently went through an US$8 million renovation, is upgraded with a premium quality HVAC system and highly insulated roof to help reduce power costs, which already are some of the lowest in California.

The company has set 2020 goal for implementation of its full-service software platform, 420 Global, which will interact with every aspect of production flow, business development and the sales process.

Growing Portfolio

Acquisitions slated to be completed in June include Goodfellas Group LLC, a full-service advertising and marketing agency for the U.S. cannabis and hemp industries. Under the deal, TransCanna will also be acquiring Daily Cannabis Goods, a pre-rolled brand with nominal start-up costs and superior SKU velocity with cannabis products available at more than 30 dispensaries throughout California.

On Deck

The company has moved to acquire organic hemp-infused CBD coconut oil Biovelle (www.Biovelle.com). Biovelle is non-GMO, vegan and gluten free, with coconut sourced from plantations in the Philippines and American grown hemp from farms in Colorado.

TransCanna has also moved to further secure a growing foothold in cannabis edibles via a non-binding letter of intent with Persuasion Brewing Co., located near the company’s flagship facility in Modesto. The goal is to establish a Persuasion Brewing division at the main facility, which will produce a variety of different CBD infusion non-alcoholic beers.

Similarly, the company has recently executed a non-binding LOI with SolDaze (Tres Ojos Naturals, LLC) to gobble up the branding asset package of this California manufacturer of cannabis-infused fruit snacks (www.soldazesnacks.com).

Management

TransCanna’s management team consists of seasoned agriculture and consumer goods-oriented veterans.

Director, CEO and Chairman James Pakulis has 30 years of experience working with public and private entrepreneurial companies in a variety of emerging sectors. He has been on the front lines of the California cannabis industry for nearly a decade. He was CEO and chairman in 2010 of General Cannabis, Inc., which wholly owned the popular Weedmaps brand. Pakulis oversaw the growth of General Cannabis from pre-embryonic stages to over $16 million in revenue in less than two years, reaching a market cap of approximately $480 million.

Director and President Arni Johannson brings over 30 years of investing experience in the Canadian capital markets. He has built and or funded over 50 startups from around the world. He is president of Canadian Nexus Ventures and has been instrumental in providing guidance to pre- and post IPO companies, as well as guidance and oversight for corporate governance.

Stephen Giblin, board director, is an accomplished leader in the global hospitality, technology and real estate industries with a demonstrated track record of value creation. Juan Pablo Flores, independent director, is an attorney with more than 25 years of legal experience with a strong background in municipal, government, real estate, corporate and general civil law litigation.

The company’s strategic advisors include individuals with extensive experience in branding, marketing, sales, distribution, production and supply chain management.

TransCanna Holdings Inc. (CSE: TCAN), closed Tuesday's trading session at $4.15, up 1.22%, on 420,920 volume with 309 trades. The average volume for the last 3 months is 137,267 and the stock's 52-week low/high is $0.76999998/$7.78999996.

Recent News

chart

Trxade Group Inc. (TRXD)

The QualityStocks Daily Newsletter would like to spotlight Trxade Group Inc. (TRXD).

Trxade Group, Inc. (OTCQB: TRXD), Trxade is an integrated pharmaceutical logistical services company that combines a web-based purchasing platform for transactions between independent pharmacies and drug manufacturers, MSO with a specialty pharmacy, and a warehouse and drug delivery service for consumers. Trxade is pleased to announce that the registration statement on Form S-1 (the "S-1 Registration Statement") previously filed with the Securities and Exchange Commission (the "SEC") was declared effective by the SEC today, July 2nd, 2019.

Trxade Group Inc. (TRXD) is an integrated pharmaceutical services company that offers a unique combination of a web-based purchasing platform (www.trxade.com) for transactions between independent pharmacists and drug distributors (B2B); a network of pharmacies with E-Hub software; a mail order pharmacy; and warehouse and drug delivery services. This synergistic combination of product offerings and superior data analytics is poised to benefit all stakeholders and consumers within the pharmaceutical industry.

Trxade will leverage and scale its fully integrated model to execute the following growth strategies:

  • Increase share of pharmacist drug purchasing
  • Additional SKUs and expand product breath
  • Partner with Specialty and International Mfg.
  • Expand mail order licenses to all 50 states
  • Scale Delivmeds for consumer delivery nationwide
  • Integration with telemedicine
  • M&A Opportunities within drug value chain

Founded in 2010 and headquartered in Tampa, Florida, Trxade's overarching corporate strategy is to penetrate the existing retail independent pharmacy marketplace and diversify the company's pharmaceutical mix with additional specialty and acute care products. Trxade is advancing on this mission by focusing on three key niches in the health care market.

Business-to-Business (B2B)

The $330 billion U.S. pharmaceutical industry is comprised of more than 65,000 pharmacy facilities and 1,500 state-licensed suppliers. Roughly 24,000 of these facilities are independent pharmacies, which collectively spend approximately $93 billion a year on branded and generic drugs.

Trxade targets these independent pharmacies, leveraging a robust, "E-Bay/Kayak-like" technology platform with optimum buyer/seller pricing algorithms, product availability, and predictive data analytics features.

Trxade currently serves and transacts with more than one-third (10,250) of these independent pharmacies and facilitates over $10 million of drug purchases a month!

Consumer

Trxade also targets the "consumer side" of the pharmaceutical industry, aiming to lower prescription drug costs by attacking the inefficient value chain; offering drug price transparency and efficient buying; and, delivering drugs DIRECT to independent pharmacists and consumers.

The company operates a full-service mail order pharmacy for U.S. consumers, as well as a mobile app called "Delivmeds" (http://www.delivmeds.com) which enables SAME DAY home delivery of dispensed prescriptions.

Retail

Trxade's Managed Services Organization ("TrxadeMSO") enables its member independent retail pharmacies to get patients, process orders, and deliver or ship prescriptions to patients. TrxadeMSO provides access to encompassing network of pharmacies through the E-Hub software, allowing for timely and comprehensive medication fulfillment.

These offerings ensure the best-suited pharmacy receives the patient's information, thereby ensuring appropriate medication coverage based on the patient's location, payor coverage, and medication access/inventory. This will save the clinicians and their staff time as they benefit from efficiency and enhanced workflow management in script processing and fulfillment.

Health Care Market

The U.S. health care market currently hovers near $4 trillion and is expected to grow as the general population ages. This growth will have greater impact on consumers as out-of-pocket expenses also rise. Additionally, drug costs are paced to increase faster than the overall health care and well above inflation.

Drug pricing is variable, and reimbursement is squeezing profits. This provides significant opportunity for the Trxade model of price visibility and profit optimization.

Trxade's fair online market platform targets the nation's retail community and independent pharmacies, of which there are approximately 24,000 nationwide. TRxADE has found that independent pharmacies, in order to be cost-effective, often operate with minimal staff and conduct up-to-the minute price checks. The TRxADE S2P platform gives these pharmacists the ability to easily compare the price of drugs offered by various suppliers and select the most favorable deals, saving money by taking advantage of best purchase pricing.

TRxADE's programs include:

  • TRxADE Exchange, which opens and widens the distribution channel to the retail, community pharmacy. A purchasing pharmacy can view products from manufacturers, buying groups, and wholesalers on a real-time and continuous basis. This approach significantly enhances the competitive spirit of the exchange where the lowest price exists for each product at any given point in time. TRxADE has become a competitive tool for all progressive entities and is recognized for its easy searching of hard-to-find generic pharmaceuticals at substantially reduced prices.
  • RX Guru™ is an industry-leading price prediction model that integrates product shortage insight into pharmacy acquisition benchmarks ("PAC") to ascertain trends and pricing variances that result in significant purchasing opportunities. RX Guru affords members the opportunity to continuously benefit from real price purchasing opportunities that are concealed from the rest of the industry.
  • Product Shortage Database – TRxADE maintains the most comprehensive retail, specialty and acute care pharmaceutical product shortage database in the country. Other industry competitors mainly restrict their efforts to specialty and acute care product shortages and narrowly research oral generic products. TRxADE's advanced prediction tools help members source those hard-to-find products at affordable costs in a timely and easy-to-search process.

Management Team

Trxade's management team is rich in expertise within the pharmaceutical supply chain and is supported by a base of advisors and contractors who are experts in related fields of the pharmaceutical sector.

Suren Ajjarapu – Chairman of the Board, Chief Executive Officer and Secretary

Suren Ajjarapu has served as Trxade's chairman of the board, CEO and secretary since 2014, and as the chairman of the board, chief executive officer and secretary of Trxade Nevada since its inception. Ajjarapu also serves as a chairman of the board for Feeder Creek Group Inc., since March 2018. Ajjarapu formerly was a founder, CEO and chairman of Sansur Renewable Energy Inc., a company involved in developing wind power sites in the Midwest, United States; a founder, president and director of Aemetis Inc., a biofuels company (AMTX.OB); a founder, chairman and CEO of International Biofuels, a subsidiary of Aemetis Inc.; and a co-founder, COO, and director at Global Information Technology Inc., an IT outsourcing and systems design company. Ajjarapu holds an M.S. in environmental engineering from South Dakota State University, Brookings, South Dakota, and an MBA from the University of South Florida, specializing in international finance and management. Ajjarapu is also a graduate of the Venture Capital and Private Equity program at Harvard University.

Prashant Patel – Director, President and Chief Operating Officer

Prashant Patel has served as Trxade's full-time president and COO, and as a director since the company's acquisition of Trxade Nevada in 2014, and as the COO and president and as a director of Trxade Nevada since its inception. He has been a president and member of the board of Trxade since August 2010. Patel is a registered pharmacist and pharmaceutical consultant with over 10 years of experience in retail pharmacy and pharmaceutical logistics. He is the founder of several pharmacies in the Tampa Bay area, in Florida. Since 2008, Patel has been managing member of the APAA LLC pharmacy. Since 2007, Patel has been a vice president of Holiday Pharmacy Inc. Patel graduated from Nottingham University School of Pharmacy and practiced in the United Kingdom before obtaining his masters in Transport, Trade and Finance from Cass Business School, City University, UK.

Trxade Group Inc. (TRXD), closed Tuesday's trading session at $0.55, even for the day, on 19,996 volume with 5 trades. The average volume for the last 3 months is 3,826 and the stock's 52-week low/high is $0.230000004/$0.75.

Recent News

chart

Organigram Holdings Inc. (TSX.V: OGI) (NASDAQ: OGI)

The QualityStocks Daily Newsletter would like to spotlight Organigram Holdings Inc. (OGI).

Organigram Holdings Inc. (NASDAQ: OGI) (TSXV: OGI), the parent company of Organigram Inc. (the "Company" or "Organigram"), a leading licensed producer of cannabis, announced today it will report its third quarter earnings results for its fiscal year ended August 31, 2019 on Monday, July 15, 2019 before market open. Also today, the company was highlighted in today's edition of Investorideas.com potcastsCM. Listen to the podcast:
http://ibn.fm/KJXrD .

Organigram Holdings Inc. (TSX.V: OGI) (NASDAQ: OGI) is the parent company of Organigram Inc., a leading Canadian licensed producer (“LP”) of high-quality cannabis and extract-based products. Founded in 2013, Organigram is focused on producing high quality, indoor-grown cannabis for patients and adult recreational consumers in Canada, as well as developing international business partnerships to expand the Company’s global footprint. 

The Company has distribution arrangements in all 10 provinces1. Organigram delivers industry-leading yields and maximizes quality cannabis production at the lowest cultivation cost per gram among publicly reporting Canadian LPs.

Financial Results

In Q2 2019, the Company reported record net revenue of C$26.9 million, cash cost of cultivation of C$0.65 per gram, industry leading gross margin of C$16 million or 60% and adjusted EBITDA of C$13.3 million or margin of 49%, positive for the third consecutive quarter.

Significant Expansion Plans with Streamlined Licensing Process

Located in Moncton, New Brunswick, Organigram’s production facility and research & development program includes a state of the art, indoor 3-tier cultivation system which maximizes facility square footage. Its Phase 4 expansion project is expected to be completed by the end of 2019 for increased target production capacity of 113,000 kg/year (249,000 lbs)2. As the Company expands its cultivation and processing capacities, Organigram is able to file amendments to the existing facility and each new production area is largely a replica of previously licensed areas, which results in a relatively streamlined and predictable licensing process with Health Canada.

In addition to increased production capacity from Phase 4, Organigram’s Phase 5 expansion includes plans for additional extraction capacity and its own edibles facility. Construction is expected to be substantially completed in October 2019.

Proprietary Technology

The Company’s indoor facility allows for control of all critical facets of the lighting and environmental elements to drive maximum quality and yield in the plants. The Company’s in-house proprietary information technology system, called OrganiGrow, tracks grow cycles, environmental conditions and other factors to optimize cultivation.

Numerous design and automation improvements include automated potting, pre-roll and packaging machines, and larger propagation rooms with advanced environmental systems.

Well Positioned for Canada’s Legalization of Edibles and Other Derivatives Products

Through its facility expansions, partnerships and research and development, the Company is well-positioned to capture further growth from the legalization of edibles and derivative products expected in October 2019. Its initial product focus is on vaporizable products and edibles.

Organigram’s development of a shelf-stable, thermally stable, water-soluble and tasteless cannabinoid nano-emulsion formulation may provide for an initial onset of effect within 10 to 15 minutes in a beverage. Non-cannabis formulations with a similar molecule size are water-soluble in humans (i.e., absorbed through the bloodstream rather than requiring first-pass liver metabolism, which results in longer onset and duration uncertainty). The Company expects to receive research and development licensing in the near term, at which point testing will be conducted to confirm the onset and duration.

Organigram has entered into an exclusive consulting agreement with The Green Solution (TGS), a proven market leader based in Denver, Colorado for the development of commercial scale extraction and derivative product development in Canada. Organigram’s partnership with Canada’s Smartest Kitchen, a leader in food product development, will expand the Company’s edibles R&D program.

The Company recently announced a C$15 million investment commitment in a high-speed, high-capacity, fully automated production line with a capacity of 4 million kilograms of exceptional chocolate cannabis edibles per year.

Organigram also has a multiyear extraction contract with Valens GroWorks Corp. to produce extract concentrate for oils and other derivative products.

Disruptive Technology

Through its partnership with Hyasynth Biologicals Inc., a biotech company and leader in the field of cannabinoid science and biosynthesis, Organigram has invested in a potentially disruptive technology that uses patented yeast strains and enzymes to naturally produce cannabinoids without growing the cannabis plant. This process has the potential to create a global supply of pure cannabinoids at a fraction of the cost of traditional cultivation. Organigram views this investment as providing early access to what it expects to be the future of cannabinoid production – cost-effectiveness, purity and scalability.

International

Organigram believes there will be increasing demand for CBD in Canada and beyond. As such, the Company has invested in Alpha-Cannabis Germany (ACG) and expects to provide ACG with flower for conversion into extracts. ACG is a medical cannabis provider serving the largest legalized medical market in Europe. The Company anticipates entering into an agreement with ACB to purchase pure synthetic CBD isolate in the future.

Organigram is also invested in Eviana Health Corp. (CSE: EHC), a Serbian-based company with hemp farming and processing assets.

Experienced Executive Team

  • CEO Gregory Engel has 30 years of national and international experience in pharmaceuticals, biotechnology, cannabis, and consumer packaged goods (CPG), and most recently served as CEO of Tilray Inc. where he was instrumental in the company becoming the first Canadian exporter of medical cannabis, as well as establishing several trailblazing industry standards
  • Jeff Purcell, Senior Vice President of operations, has 25 years of experience in operations for companies such as Ganong Chocolates and McCain Foods
  • Tim Emberg, Senior Vice President of Sales and Commercial operations, has 20 years of experience in pharmaceutical sales and marketing in the OTC and CPG industries
  • Paolo DeLuca, Chief Financial Officer, has 20 years of diversified financial business experience including with West Face Capital and TD Securities
  • Ray Gracewood, Senior Vice President, Marketing & Communications, has 15 years of experience in the marketing space and was senior Director of Dales and Marketing for Moosehead Breweries Ltd.

This profile contains certain non-IFRS performance measures including cash and all-in cost of cultivation per gram, net revenue, adjusted EBITDA, and adjusted gross margin which are not calculated in accordance with IFRS and may not be comparable to similar data presented by other companies. Please see the company’s Q2 2019 MD&A.

1 Subject to final regulatory approval from Quebec
2 Several factors can cause actual capacity and costs to differ from estimates. See “Risks and Uncertainties” in the Company’s Q2 2019 MD&A and “Risk Factors” in the latest Annual Information Form.

Organigram Holdings Inc. (NASDAQ: OGI), closed Tuesday's trading session at $6.29, off by 4.41%, on 566,562 volume with 1,959 trades. The average volume for the last 3 months is 935,175 and the stock's 52-week low/high is $2.97000002/$8.43999958.

Recent News

chart

Plus Products Inc. (CSE: PLUS) (OTC: PLPRF)

The QualityStocks Daily Newsletter would like to spotlight Plus Products Inc. (CSE: PLUS) (OTC: PLPRF).

Plus Products Inc. (CSE:PLUS) (OTCQX:PLPRF), today announces the closing of certain warrant exercises. Such warrant exercises occurred in connection with the previously announced acceleration of the expiry date of the certain warrants previously issued by the Company’s wholly-owned subsidiary, Plus Products Holdings Inc.

Plus Products Inc. (CSE: PLUS) (OTC: PLPRF) is a branded cannabis-infused products manufacturer of edibles created to support a healthy and active lifestyle. Headquartered in San Mateo, California, PLUS™ concentrates on producing edibles using extracts to ensure compliant, dosable and delicious products that provide a consistent cannabis experience.

First introduced to the market in 2015 to rave reviews, PLUS™ is now one of the top best-selling edible brands in California. PLUS™ operates through a wholly owned subsidiary, Carberry, and has four cannabis-infused gummy candy SKUs (in addition to limited edition SKUs), that are currently sold in over 200 licensed dispensaries and delivery services. All products under the PLUS™ brand are produced in the company’s 12,000-square-foot food-safe cannabis manufacturing facility in Adelanto, California.

PLUS Products shares are currently listed on the Canadian Securities Exchange. PLUS™ raised CAD$20 million through the offering, for which the lead underwriters were PI Financial and Canaccord Genuity. The company intends to use a portion of the IPO proceeds to fund rapid product capacity expansion, factory automation, working capital and new product development.

Operating in the largest adult-use recreational market in the U.S., PLUS Products holds a temporary manufacturing license in California and was one of the first brands to bring fully compliant products to the legal market. California legalized adult use recreational sales on Jan. 1, 2018, and industry analysts expect edible sales there will continue to amass enviable revenues. According to BDS Analytics, edibles made up 18 percent of marijuana retail sales in February 2018 across licensed retailers in California, with PLUS™ products ranking in the Top 10 of edible brands by retail dollar sales.

During the first half of 2018, PLUS Products generated US$2.45 million in sales, a marked improvement over 2017’s US$1.07 million in sales. The company’s established cannabis products are not only compliant with state laws, they are proving to be extremely popular with consumers. Among the PLUS™ product brands are:

  • Blackberry & Lemon RESTORE, an infusion of carefully dosed cannabis with a 9:1 THC to CBD per gummy.
  • Sour Watermelon UPLIFT, a low-calorie gummy crafted from carefully dosed cannabis with an infusion of 5mg THC per gummy.
  • Pineapple & Coconut CBD RELIEF, a tropical flavor gummy made from pure cannabis-derived CBD that is low-calorie, gluten-free and made with kosher ingredients.
  • Sour Blueberry CREATE, a low-calorie gummy infused with hybrid flower containing 5 mg THC.
  • Limited Edition Rose & Vanilla, available at select locations during Winter 2018, these gummies are crafted with 60 mg THC/30 mg CBD per tin.
  • Limited Edition RAINBOW SORBET gummies was created to celebrate Pride during Spring 2018 with a portion of each purchase donated to The Trevor Project, a confidential suicide hotline for LGBT youth.

“We are extremely proud of the products PLUS has brought to market,” remarked Jake Heimark, CEO and cofounder in a statement. “We’ve quickly grown into one of the leading edible brands in California. With the proceeds of this round, we will continue to further our mission: to make cannabis safe and approachable for all types of consumers.”

The PLUS™ team believes that everyone deserves access to consistent, dosable and delicious cannabis products and strives to make that happen. Producing the best infused products at scale requires thoughtful collaboration among experts in many fields. At PLUS™, our team is comprised of Chefs, Chemists, Food Manufacturing Experts, Engineers, Machinists, Visionaries, Creatives, Strategists and others.

Plus Products Inc. (PLPRF), closed Tuesday's trading session at $2.6428, off by 6.41%, on 46,959 volume with 126 trades. The average volume for the last 3 months is 74,300 and the stock's 52-week low/high is $2.54999995/$6.00810003.

Recent News

chart

Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF)

The QualityStocks Daily Newsletter would like to spotlight Green Growth Brands Inc. (OTCQB: GGBXF).

Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) was highlighted in a publication from Financialnewsmedia.com, examining how demand for CBD is on the rise all over the world.  All as cannabis-infused products find their way onto the shelves of major retailers, with analysts believing the trend provide a significant catalyst. Piper Jaffray, for example, believes the CBD market alone could be worth up to $100 billion.

Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) is a lifestyle-oriented cannabis and cannabidiol (“CBD”) consumer products company with a portfolio of lifestyle brands customized to connect specific, like-minded customers. Each Green Growth Brand provides the best quality products within a retail experience that appeals to users in an environment that is emotionally branded and easy to navigate.

In the next five years, the cannabis industry will generate more than $28 billion of new revenue from an estimated 14 million new customers, according to Ackrell Capital’s 2018 Cannabis Investment Report. Meanwhile, Hemp Business Journal projects that the CBD market will increase 8x to $3 billion by 2021, up from $200 million in 2017. Green Growth Brand intends to dominate in these markets with a lineup up products grown, manufactured and presented with the highest quality standards in mind.

Products under the Green Growth Brand umbrella include:

  • CAMP: A kiosk-type store where consumers can experience beautifully crafted lifestyle products that enhance one’s journey to self-discovery.
  • Seventh Sense: A CBD-infused body care collection crafted from the finest botanicals and fragrances on earth. Created to maximize the properties and aromatics of each ingredient, Seventh Sense natural products are CBD-infused botanical therapy.
  • Meri+Jayne: Fiercely authentic and wholly unapologetic, Meri+Jayne is a youthful, full-on celebration of what makes each person unique. Expect the unexpected when it comes to this mix of amazing products.
  • Green Lily: A place for women to explore a new world of wellness. With advice on every product, from efficacy to usage, Green Lily guides guests through beautiful new ways to experience cannabis and CBD.
  • The +Source: Located in Las Vegas and Henderson, Nevada, The+Source dispensaries operated by Green Growth Brands serve both medical patients and retail customers. Green Growth Brands also operates a grow and production facility in Post, Nevada, and recently entered into definitive agreements to acquire a Pahrump, Nevada, cultivation facility.
  • XanthicBiopharms is the owner of valuable intellectual property that turns THC(Tetrahydrocannabinol) and CBD into a water-soluble substance. As a result of combining Green Growth Brands and Xanthic, this technology is being used to create incredible new products.

Business Strategy

Green Growth Brands has identified numeroushitches in the current cannabis retail space. The company intends to counter these challenges and provide a customer experience ripe with a friendly staff, in-stock assortments, efficient operations and more. The company’s retail partners provide distribution opportunities within 4,000 stores, as well as robust and established digital platforms to best reach the modern consumer.

Management

Green Growth Brands brings together a collection of expert retailers, scientists, botanists, developers, artists and business leaders for the benefit of building community. Led by an executive management team steeped in decades of experience with several of America’s most successful brands, including Victoria’s Secret, American Eagle Outfitters, Bath & Body Works, Limited Brands and Designer Shoe Warehouse, Green Growth Brands is uniquely positioned to create memorable brands, retail experiences, and quality products for the emerging cannabis industry.

Chief Executive Officer Peter Horvath heads strategy and execution across all company channels, and previously took shoe retailer DSW public on the NYSE at $1.5 billion. As a dynamic, creative brand leader, team builder, and specialty retail veteran with deep roots in finance, Horvath’s unique ability to understand the big picture while never missing the subtle details is a critical factor in Green Growth Brands’ success and brand popularity among customers.

Chief Marketing Officer Scott Razek is a brand strategist, storyteller and strategic marketer. Razek‘s 25 years of experience in brand building, product development and customer experience focus are a key differentiator for the Green Growth Brands portfolio.

CAO Ed Kistner brings 33 years of multifaceted experience at leading retail businesses, notably in finance, merchandise planning, operations and stores. His well-rounded experiences in fast-changing environments position Kistner to be the architect of the operational execution at Green Growth Brands.

CSO Kellie Wurtzman brings significant retail leadership to Green Growth Brands with a proven track record of leading high-performance stores and teams across multiple retail sectors. Her unmatched experience in identifying and supporting developing business opportunities is ideal for evolving the cannabis industry and will be instrumental in expanding operations at Green Growth Brands.

Headquartered in Columbus, Ohio, Green Growth Brands is traded on the Canadian Securities Exchange and on the OTCQB, providing investors with increased access to data, transparency and liquidity.

Green Growth Brands Inc. (OTCQB: GGBXF), closed Tuesday's trading session at $2.1918, off by 2.59%, on 428,127 volume with 624 trades. The average volume for the last 3 months is 282,420 and the stock's 52-week low/high is $1.8068/$5.20499992.

Recent News

chart

The Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF)

The QualityStocks Daily Newsletter would like to spotlight Supreme Cannabis Company Inc. (OTC: SPRWF).

The Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF) was highlighted in a publication from Financialnewsmedia.com, examining how Piper Jaffray, for example, believes the CBD market alone could be worth up to $100 billion.  In addition, according to Arcview Market Research and BDS Analytics, global spending on cannabis could reach $57 billion by 2027.

Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF), is committed to providing premium brands and products that reflect the company’s knowledgeable customers, passionate employees, and culture of innovation. Supreme Cannabis’ mission is to grow the world’s best cannabis and become a leader in the global industry. The company calls its Toronto Venture Exchange stock symbol FIRE “a testament to our passion for cannabis and our obsession with quality.”

Supreme Cannabis believes the world is ready to follow Canada’s lead by ending the 100-year cannabis prohibition and, as Canada’s only coast-to-coast premium cannabis producer, the company sees itself at the center of this global shift.

In August 2018, Supreme Cannabis uplisted its shares to the to OTCQX market in the U.S., where the company trades under the ticker symbol SPRWF. The following month Supreme reported record Q4 revenues of CAD$3.55 million, a 71-percent increase over the previous quarter. Supreme Cannabis also recorded revenue of CAD$8.85 million for its fiscal year ended June 30, 2018, placing it among publicly traded Canadian cannabis companies with the highest reported revenue in their first four quarters of sales.

“As a result of the successful execution of our strategy, we have generated significant revenue growth both for the quarter and the year-end period,” Supreme Cannabis CEO Navdeep Dhaliwal stated in a news release. “We look forward to building on this growth as we expand domestically and internationally.”

The company’s growth strategy includes key industry agreements, such as its CAD$12 million supply agreement with Tilray Inc. (OTC: TLRY), a global leader in cannabis research, cultivation, processing and distribution. The agreement calls for Supreme to supply Tilray with dried cannabis for support of medical cannabis patients in Canada for the period of one year.

Another key component is the company’s wholly owned 7ACRES subsidiary. The 7ACRES cultivation facility, one of the first 40 federally licensed cannabis producers in Canada, is focused on building a core competency in scaled cannabis production, which will give 7ACRES the needed flexibility to maintain leadership in the industry as the Canadian market grows and matures. Though 7ACRES is Supreme Cannabis’ flagship brand and only currently operating business unit, the company will continue to identify new opportunities to grow its portfolio of companies and build innovative cannabis businesses throughout the world.

7ACRES operates from a 342,000-square-foot cultivation facility in Kincardine, Ontario, and has been federally licensed since 2016. Current capacity is 13,333 kilograms dried cannabis annually, with plans to ramp up production by mid-2019 to a rate of 50,000 kilograms per year.

Supreme Cannabis seeks to differentiate 7ACRES from other licensed cannabis producers by producing premium quality product sustainably at scale. “Craft quality, commercial scale” is a slogan the company uses, and the Kincardine greenhouse employs state-of-the-art technology and cultivation best practices to strive toward that goal. Supreme identifies the quality of the 7ACRES product as the company’s primary strength and says a shared “passion for the plant” is the driver of company culture. Six Canadian provinces have signed supply agreements with Supreme, a fact the company credits to the high quality of 7ACRES cannabis.

Its customers, Supreme Cannabis management says, are informed and discerning regarding cannabis, and they value a premium brand that respects their product knowledge. The company believes its high regard for customers, premium product quality, and mass cultivation capability has allowed Supreme Cannabis to emerge as Canada’s preeminent premium cannabis producer. In the Canadian cannabis market, the company has established 7ACRES as a premium brand that’s distributed coast-to-coast and commands premium pricing. The 7ACRES brand is already listed as premium cannabis product in all provinces that disclose their cannabis listing categories, and 7ACRES on average wholesales for up to one-third higher in price than other brands in the Canadian cannabis market.

To further its distribution, in the medical cannabis market Supreme Cannabis has partnered with several Canadian cannabis retailers including Aurora Cannabis, Emerald Health Botanicals, Namaste, Zenabis, and others. The company’s investment portfolio also includes an equity position and long-term global distribution partnership with Medigrow, based in Lesotho, targeting the export of medical cannabis oil for the international market.

Supreme Cannabis seeks to make the company an innovator in the cannabis sector regarding design of cultivation facilities and development of operation excellence metrics. The management team is confident that the 7ACRES flagship brand, the company’s proprietary technology and products, and the company’s culture of passion for cannabis will deliver consistent long-term shareholder value.

Supreme Cannabis Company Inc. (OTC: SPRWF), closed Tuesday's trading session at $1.15, off by 0.86%, on 136,926 volume with 228 trades. The average volume for the last 3 months is 349,652 and the stock's 52-week low/high is $0.850000023/$2.03999996.

Recent News

chart

IONIC Brands Corp. (CSE: IONC) (OTC: IONKF)

The QualityStocks Daily Newsletter would like to spotlight IONIC Brands Corp. (OTC: IONKF).

West Coast-based cannabis holding company IONIC Brands (CSE: IONC) (OTC: IONKF) (FRA: IB3) this morning announced its entry into an exclusive Heads of Agreement with Lifespot Health Limited (ASX: LSH) to develop and distribute Lifespot’s software and vaporizer technologies. To view the full press release, visit: http://nnw.fm/HvjR0.

IONIC Brands Corp. (CSE: IONC) (OTC: IONKF) is a national cannabis holding company building a multistate portfolio of award-winning premium and luxury brands in the cannabis space. Established in 2015, IONIC Brands has demonstrated its ability to expand and operate multiple cannabis concentrate consumer brands in markets across the western United States. The company continues to strategically expand nationwide to remain a leader of the highest-value segments in the cannabis market.

With a focus on quality, responsibility and respectability, IONIC's product lines are pioneering the changing landscape of cannabis consumption. The company's refinement practices are a result of a passionate commitment to craft the finest, small-batch cannabis oils and cannabis concentrates in the world – without glycols, glycerins or additives.

IONIC's Certified Clean program verifies that every product leaving the company's facilities meets or exceeds state mandates on pesticide testing. The testing is conducted by individually testing every batch which ensures and enhances trust and transparency. IONIC recently paired its Certified Clean program with Lucid Green Inc. and its revolutionary technology platform designed to provide vital safety information. Lucid Green's technology provides a direct-to-consumer data platform, providing instant access to a library of product specific insights by simply scanning the package's QR code with a smartphone camera.

Elite Brand Portfolio/Acquisitions

  • IONIC, the company's flagship recreational branded product, is a stylish and sophisticated premium vape pen line that has earned customer loyalty and a reputation as a consistent Top 10 vape brand in Washington state. IONIC's immediate product line expansion plans include THC/CBD mixes, low-dose products, high-end edibles, CASK oil and device innovation.
  • WW Agriculture cultivates cannabis outdoors on a 140-acre eastern Washington State farm capable of producing up to 100,000 pounds of cannabis for less than $0.10/gram.
  • ZOOTS, a Washington-based edibles company, utilizes patent-protected ultra-clean CO2 extraction hardware to create proprietary formulations of refined cannabis oils and distillates. Through MedMen dispensaries, Zoots Edibles are currently available in Washington and Colorado and will soon be on shelves at dispensaries in Massachusetts, New York and Pennsylvania.
  • Vuber Technologies hardware produces the best vaporization experience on the market.
  • Vegas M Stick vaporizer pens are distributed to stores in Washington State with plans to expand to Oregon and Nevada.
  • Vegas Valley Growers is a revenue-generating, vertically integrated operation in Las Vegas, Nevada, with a full complement of production, manufacturing and distribution licenses.

IONIC has also acquired two U.S. patents issued to Canna Café that are related to cannabinoid (CBD) infused coffee and CBD-infused coffee in a Keurig ® K-Cup ® Pod. An international patent is in process for cannabis-infused teas.

Experienced Management Team

IONIC Brands is led by an innovative product team, powerful sales organization and a world-class marketing group.

Chairman & CEO John Gorst has built and sold four different technology companies with market valuations in excess of $600 million. Gorst has been at the forefront of IONIC's expansion and development into Washington state's leading vaporizer brand.

Andrew Schell, President, Vice-Chairman & Co-Founder, has built several successful companies. Schell has an engineering background rounded in operations, strategy and corporate law, and most recently was CEO of a U.S. Department of Defense company specializing in military operations.

Christian Struzan, Chief Marketing Officer & Co-Founder, has over 30 years of experience in marketing and branding in the entertainment and consumer goods industries. Struzan founded an advertising agency which developed and executed marketing campaigns for feature films such as the Star Wars franchise, Fight Club, and the television series American Idol. He has also worked on global brands such as Guinness, Stella Artois and Beck's.

Johnny Stange, Chief Revenue Officer, was formerly a director of sales for the southern California region for Treasury Wine Estates, a major wine wholesaler, where he grew and oversaw annual sales of $250 million. Stange is leading the charge in IONIC's aggressive sales growth plans across multiple states.

In 2018, IONIC was voted one of the "Top 50 Companies to Work for in Cannabis" by MG Magazine, a publication serving cannabis industry professionals.

IONIC Brands Corp. (OTC: IONKF), closed Tuesday's trading session at $0.2308, off by 11.23%, on 149,809 volume with 84 trades. The stock's 52-week low/high is $0.20/$0.26.

Recent News

chart

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

ActionStockPicksAgressive StocksBetting On Wall StreetCannabisNewsWireGot Stocks?Got Stock Tips?Green Car StocksGreen Energy StocksGreen On The StreetHomeRunStocksMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireQualityStocks MediaQStocksQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsStock BeatsStocks To Buy NowTerrificStocksTiny GemsTip.usTouchdownStocksDaily ToutTraderPower

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.